US20080166706A1 - Novel gold nanoparticle aggregates and their applications - Google Patents
Novel gold nanoparticle aggregates and their applications Download PDFInfo
- Publication number
- US20080166706A1 US20080166706A1 US11/396,098 US39609806A US2008166706A1 US 20080166706 A1 US20080166706 A1 US 20080166706A1 US 39609806 A US39609806 A US 39609806A US 2008166706 A1 US2008166706 A1 US 2008166706A1
- Authority
- US
- United States
- Prior art keywords
- chemical sensor
- group
- sers
- fiber
- molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000010931 gold Substances 0.000 title claims abstract description 55
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 title claims abstract description 53
- 229910052737 gold Inorganic materials 0.000 title claims abstract description 53
- 239000002105 nanoparticle Substances 0.000 title abstract description 81
- 238000000034 method Methods 0.000 claims abstract description 89
- 239000000427 antigen Substances 0.000 claims abstract description 67
- 108091007433 antigens Proteins 0.000 claims abstract description 65
- 102000036639 antigens Human genes 0.000 claims abstract description 65
- 230000003287 optical effect Effects 0.000 claims abstract description 46
- 230000003595 spectral effect Effects 0.000 claims abstract description 16
- 238000004891 communication Methods 0.000 claims abstract description 15
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 claims description 137
- 239000000835 fiber Substances 0.000 claims description 125
- 239000000126 substance Substances 0.000 claims description 64
- 239000002245 particle Substances 0.000 claims description 30
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 27
- 229910052709 silver Inorganic materials 0.000 claims description 27
- 239000004332 silver Substances 0.000 claims description 27
- 229910052751 metal Inorganic materials 0.000 claims description 26
- 239000002184 metal Substances 0.000 claims description 26
- 230000027455 binding Effects 0.000 claims description 21
- 108090000623 proteins and genes Proteins 0.000 claims description 21
- 239000004065 semiconductor Substances 0.000 claims description 20
- 102000004169 proteins and genes Human genes 0.000 claims description 19
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 18
- 239000002096 quantum dot Substances 0.000 claims description 18
- -1 Boc group Chemical group 0.000 claims description 15
- 239000012491 analyte Substances 0.000 claims description 14
- 206010033128 Ovarian cancer Diseases 0.000 claims description 12
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 12
- 230000005670 electromagnetic radiation Effects 0.000 claims description 12
- 239000011521 glass Substances 0.000 claims description 9
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 9
- 239000000439 tumor marker Substances 0.000 claims description 7
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 claims description 6
- 150000002632 lipids Chemical class 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 5
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims description 5
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 5
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 5
- 108091093037 Peptide nucleic acid Proteins 0.000 claims description 4
- XOCUXOWLYLLJLV-UHFFFAOYSA-N [O].[S] Chemical compound [O].[S] XOCUXOWLYLLJLV-UHFFFAOYSA-N 0.000 claims description 4
- 230000001268 conjugating effect Effects 0.000 claims description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 4
- 239000002158 endotoxin Substances 0.000 claims description 4
- 229920006008 lipopolysaccharide Polymers 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 125000003386 piperidinyl group Chemical group 0.000 claims description 4
- 235000000346 sugar Nutrition 0.000 claims description 4
- 150000008163 sugars Chemical class 0.000 claims description 4
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 4
- 239000000919 ceramic Substances 0.000 claims description 3
- 229910052763 palladium Inorganic materials 0.000 claims description 3
- 229910052697 platinum Inorganic materials 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- 229910052782 aluminium Inorganic materials 0.000 claims description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 2
- 229910052793 cadmium Inorganic materials 0.000 claims description 2
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- 229910052741 iridium Inorganic materials 0.000 claims description 2
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052703 rhodium Inorganic materials 0.000 claims description 2
- 239000010948 rhodium Substances 0.000 claims description 2
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 2
- 150000003568 thioethers Chemical group 0.000 claims 2
- 238000001514 detection method Methods 0.000 abstract description 37
- 239000007864 aqueous solution Substances 0.000 abstract description 5
- 230000001976 improved effect Effects 0.000 abstract description 5
- 230000009977 dual effect Effects 0.000 abstract description 2
- HZYWFQBABNUAAP-UHFFFAOYSA-N gold;hydrochloride Chemical compound Cl.[Au] HZYWFQBABNUAAP-UHFFFAOYSA-N 0.000 abstract 1
- 150000003463 sulfur Chemical class 0.000 abstract 1
- 239000012615 aggregate Substances 0.000 description 79
- XGRLSUFHELJJAB-JGSYTFBMSA-M sodium;[(2r)-2-hydroxy-3-[(z)-octadec-9-enoyl]oxypropyl] hydrogen phosphate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)([O-])=O XGRLSUFHELJJAB-JGSYTFBMSA-M 0.000 description 69
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 67
- 238000001069 Raman spectroscopy Methods 0.000 description 59
- 239000000758 substrate Substances 0.000 description 59
- 239000000243 solution Substances 0.000 description 37
- 238000010521 absorption reaction Methods 0.000 description 33
- 239000000523 sample Substances 0.000 description 25
- 230000005284 excitation Effects 0.000 description 22
- 239000002082 metal nanoparticle Substances 0.000 description 22
- 238000000479 surface-enhanced Raman spectrum Methods 0.000 description 22
- 239000010408 film Substances 0.000 description 21
- 238000002474 experimental method Methods 0.000 description 18
- 238000009826 distribution Methods 0.000 description 17
- 238000001237 Raman spectrum Methods 0.000 description 16
- 230000003993 interaction Effects 0.000 description 16
- 238000005424 photoluminescence Methods 0.000 description 15
- 238000010791 quenching Methods 0.000 description 15
- 230000000171 quenching effect Effects 0.000 description 15
- 206010028980 Neoplasm Diseases 0.000 description 14
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 14
- VYXSBFYARXAAKO-WTKGSRSZSA-N chembl402140 Chemical compound Cl.C1=2C=C(C)C(NCC)=CC=2OC2=C\C(=N/CC)C(C)=CC2=C1C1=CC=CC=C1C(=O)OCC VYXSBFYARXAAKO-WTKGSRSZSA-N 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 14
- 230000035945 sensitivity Effects 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 12
- 239000012634 fragment Substances 0.000 description 12
- 125000005647 linker group Chemical group 0.000 description 12
- 239000013307 optical fiber Substances 0.000 description 12
- 238000001228 spectrum Methods 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 229910004042 HAuCl4 Inorganic materials 0.000 description 10
- 150000001413 amino acids Chemical class 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000000090 biomarker Substances 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 201000011510 cancer Diseases 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 230000008901 benefit Effects 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 102000015636 Oligopeptides Human genes 0.000 description 7
- 108010038807 Oligopeptides Proteins 0.000 description 7
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 7
- 125000002252 acyl group Chemical group 0.000 description 7
- 238000003384 imaging method Methods 0.000 description 7
- 238000003018 immunoassay Methods 0.000 description 7
- 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 230000005855 radiation Effects 0.000 description 7
- 229910052979 sodium sulfide Inorganic materials 0.000 description 7
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 239000002078 nanoshell Substances 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 229910052717 sulfur Inorganic materials 0.000 description 6
- 239000011593 sulfur Substances 0.000 description 6
- 238000004809 thin layer chromatography Methods 0.000 description 6
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 5
- 239000007995 HEPES buffer Substances 0.000 description 5
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 5
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 5
- 239000002156 adsorbate Substances 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 5
- 230000008878 coupling Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 229940127121 immunoconjugate Drugs 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 238000005498 polishing Methods 0.000 description 5
- 241000283707 Capra Species 0.000 description 4
- 239000004215 Carbon black (E152) Substances 0.000 description 4
- 108060003951 Immunoglobulin Proteins 0.000 description 4
- 239000012901 Milli-Q water Substances 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 125000003275 alpha amino acid group Chemical group 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 210000004408 hybridoma Anatomy 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 150000002430 hydrocarbons Chemical class 0.000 description 4
- 102000018358 immunoglobulin Human genes 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 108091008874 T cell receptors Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 210000003719 b-lymphocyte Anatomy 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 238000005266 casting Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000012875 competitive assay Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000005672 electromagnetic field Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000016784 immunoglobulin production Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 238000004020 luminiscence type Methods 0.000 description 3
- DVYVMJLSUSGYMH-UHFFFAOYSA-N n-methyl-3-trimethoxysilylpropan-1-amine Chemical compound CNCCC[Si](OC)(OC)OC DVYVMJLSUSGYMH-UHFFFAOYSA-N 0.000 description 3
- 150000002894 organic compounds Chemical class 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 238000011896 sensitive detection Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000009870 specific binding Effects 0.000 description 3
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 2
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 2
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 2
- 241000283074 Equus asinus Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 238000003332 Raman imaging Methods 0.000 description 2
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 230000035508 accumulation Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 230000001621 anti-mitogenic effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 230000022131 cell cycle Effects 0.000 description 2
- 230000012292 cell migration Effects 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000036755 cellular response Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000005253 cladding Methods 0.000 description 2
- 230000001427 coherent effect Effects 0.000 description 2
- 230000009137 competitive binding Effects 0.000 description 2
- 230000009918 complex formation Effects 0.000 description 2
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 238000001663 electronic absorption spectrum Methods 0.000 description 2
- 230000005274 electronic transitions Effects 0.000 description 2
- 230000009881 electrostatic interaction Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002923 metal particle Substances 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000002297 mitogenic effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000004899 motility Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 238000010647 peptide synthesis reaction Methods 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 229920000447 polyanionic polymer Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 238000006862 quantum yield reaction Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 239000012723 sample buffer Substances 0.000 description 2
- 238000002444 silanisation Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 229910001961 silver nitrate Inorganic materials 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 239000012798 spherical particle Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 125000000101 thioether group Chemical group 0.000 description 2
- 239000000107 tumor biomarker Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- KYRUKRFVOACELK-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(4-hydroxyphenyl)propanoate Chemical compound C1=CC(O)=CC=C1CCC(=O)ON1C(=O)CCC1=O KYRUKRFVOACELK-UHFFFAOYSA-N 0.000 description 1
- BQCIDUSAKPWEOX-UHFFFAOYSA-N 1,1-Difluoroethene Chemical compound FC(F)=C BQCIDUSAKPWEOX-UHFFFAOYSA-N 0.000 description 1
- YNDYKPRNFWPPFU-UHFFFAOYSA-N 1-palmitoylglycerol 3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP(O)(O)=O YNDYKPRNFWPPFU-UHFFFAOYSA-N 0.000 description 1
- LAYXSTYJRSVXIH-HXUWFJFHSA-N 1-stearoyl-sn-glycero-3-phosphate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(O)(O)=O LAYXSTYJRSVXIH-HXUWFJFHSA-N 0.000 description 1
- UUEWCQRISZBELL-UHFFFAOYSA-N 3-trimethoxysilylpropane-1-thiol Chemical compound CO[Si](OC)(OC)CCCS UUEWCQRISZBELL-UHFFFAOYSA-N 0.000 description 1
- 241001609773 Campion Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 229910004613 CdTe Inorganic materials 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 241001580017 Jana Species 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 241000289371 Ornithorhynchus anatinus Species 0.000 description 1
- 101710160107 Outer membrane protein A Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920003295 Radel® Polymers 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000289674 Vombatidae Species 0.000 description 1
- 241001441284 Zeidae Species 0.000 description 1
- XEIPQVVAVOUIOP-UHFFFAOYSA-N [Au]=S Chemical compound [Au]=S XEIPQVVAVOUIOP-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 230000002788 anti-peptide Effects 0.000 description 1
- QZPSXPBJTPJTSZ-UHFFFAOYSA-N aqua regia Chemical compound Cl.O[N+]([O-])=O QZPSXPBJTPJTSZ-UHFFFAOYSA-N 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000005112 continuous flow technique Methods 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- VDQVEACBQKUUSU-UHFFFAOYSA-M disodium;sulfanide Chemical compound [Na+].[Na+].[SH-] VDQVEACBQKUUSU-UHFFFAOYSA-M 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004870 electrical engineering Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 150000002343 gold Chemical class 0.000 description 1
- CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 1
- HCDGVLDPFQMKDK-UHFFFAOYSA-N hexafluoropropylene Chemical group FC(F)=C(F)C(F)(F)F HCDGVLDPFQMKDK-UHFFFAOYSA-N 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- GDJYIXGPYCKDOV-UHFFFAOYSA-N n-phenylthiohydroxylamine Chemical compound SNC1=CC=CC=C1 GDJYIXGPYCKDOV-UHFFFAOYSA-N 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000000241 photoluminescence detection Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000352 poly(styrene-co-divinylbenzene) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920005594 polymer fiber Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 238000002165 resonance energy transfer Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000013391 scatchard analysis Methods 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- NWOPIWLNGYLZCJ-GMUIIQOCSA-M sodium [(2R)-3-hexadecanoyloxy-2-hydroxypropyl] hydrogen phosphate Chemical compound [Na+].CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(O)([O-])=O NWOPIWLNGYLZCJ-GMUIIQOCSA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 230000009258 tissue cross reactivity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54346—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
- G01N21/658—Raman scattering enhancement Raman, e.g. surface plasmons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/553—Metal or metal coated
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/587—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
Definitions
- the present invention relates to particles comprising a metallic core and sulfur species on their surface with useful properties.
- the invention further relates to methods of using the particles for detecting chemical and biological analytes, and in use in optical communications.
- Raman spectroscopy is a powerful optical technique for detecting and analyzing molecules. Its principle is based on detecting light scattered off a molecule that is shifted in energy with respect to the incident light. The shift, called Raman shift, is characteristic of individual molecules, reflecting their vibrational frequencies that are like fingerprints of molecules. As a result, the key advantage of Raman spectroscopy is its molecular specificity while its main limitation is the small signal due to low quantum yield of Raman scattering.
- One way to enhance the Raman signal is to tune the excitation wavelength to be on resonance with an electronic transition, so called resonance Raman scattering. This can usually produce an enhancement on the order of 10 2 -10 3 .
- SERS surface enhanced Raman spectroscopy
- SERS can also be developed into a molecular imaging technique for biomedical and other applications. Existing Raman imaging equipment should be usable for SERS imaging. SERS will provide a much-enhanced signal and thereby significantly shortened data acquisition time, making the technique practically useful for medical or other commercial and industrial applications including chip inspection or chemical monitoring. SERS is also useful for detecting other cancer biomarkers that can interact or bind to the MNP surface. For example, Sutphen et al. have recently shown that lysophospholipids (LPL) are potential biomarkers of ovarian cancer (Sutphen et al. (2004) Cancer Epidemiol. Biomarker Prev. 13: 1185-1191).
- LPL lysophospholipids
- the incident light has to be on resonance with the substrate absorption. Only those nanoparticle aggregates that have resonance absorption of the incident light are expected to be SERS active. It is thus extremely beneficial to have a narrow size/shape distribution and thereby narrow optical absorption.
- Fluorescent nanoparticles such as semiconductor quantum dots, SQDs
- QDs quantum dots
- SQDs semiconductor quantum dots
- Metal nanoparticles have been recognized for their unique optical properties that could be exploited in optoelectronic devices.
- Nanoparticle systems composed of gold, for example, have distinct optical properties that make them amenable to study by Raman scattering.
- the Raman spectrum of the adsorbed species is significantly enhanced by 10 to 15 orders of magnitude when the metal nanoparticles have aggregated, leading to enhanced electromagnetic field effects near the surface that increases the Raman scattering intensity.
- the greater sensitivity found in the surface enhanced Raman spectroscopy (SERS) of metal nanoparticle aggregates facilitates the detection and analysis of a whole host of molecules that were previously difficult to study.
- SERS surface enhanced Raman spectroscopy
- U.S. Pat. No. 6,699,724 to West et al. describes a chemical sensing device and method (nanoshell-modified ELISA technique) based on the enzyme-linked immunoadsorbant assay (ELISA).
- the chemical sensing device can comprise a core comprising gold sulfide and a surface capable of inducing surface enhanced Raman scattering (SERS).
- SERS surface enhanced Raman scattering
- the nanoparticle is disclosed as having a silica core and a gold shell.
- the patent discloses that an enhancement of 600,000-fold (6 ⁇ 10 5 ) in the Raman signal using conjugated mercaptoaniline was observed.
- Raman amplifiers are also expected to be used globally as a key device in next-generation optical communications, for example, in wavelength-division-multiplexing (WDM) transmission systems.
- Raman scattering occurs when an atom absorbs a photon and another photon of a different energy is released. The energy difference excites the atom and causes it to release a photon with low energy; therefore, more light energy is transferred to the photons in the light path.
- FIG. 6 shown how the Raman amplifier operates.
- the Raman amplification process begins as a seed beam (incoming light) passes through the optical fiber. While it is traveling, a stronger pump beam is released from another light source and is deflected using a refractive material, such as a mirror. The pump beam and seed beam then come in contact with each other and the seed beam depletes the energy of the pump beam; therefore the intensity of the light increases and the signal is amplified. Now the signal is capable of traveling long distances, for example, more than 70 km, without losing a signal. (See, for example, U.S. Pat. No. 6,292,288; Vinson and Webb (2001) Light Amplification: The Future Of Optical Communications, Optical Engineering UCSC, Summer Ventures of Science and Math, 2001, 7 pp.)
- the present invention provides a chemical sensor comprising a plurality of particles, each particle comprising: a core, a shell having at least one surface and having contact with the core and wherein the shell comprises a sulfur-oxygen molecular species, and wherein the particle has been selectively sized using a notch filter and electromagnetic radiation, the electromagnetic radiation having a spectral wavelength of between about 350 nm and about 1075 nm.
- the particle has a size in the range of about 60 and 200 nm.
- the particle has a size selected from the range of between about 60 and 150 nm, between about 60 and 100 nm, between about 60 and 80 nm, between about 80 and 200 nm, between about 80 and 150 nm, between about 80 and 100 nm, between about 100 and 200 nm, between about 100 and 150 nm, and between about 150 and 200 nm.
- the core comprises a metal selected from the group consisting of gold, silver, platinum, copper, aluminum, palladium, cadmium, iridium, and rhodium. In a more preferred embodiment the core comprises gold.
- the electromagnetic radiation has a spectral wavelength of between about 350 nm and about 650 nm and between about 950 nm and about 1075 nm. In yet a more preferred embodiment the electromagnetic radiation has a spectral wavelength of between about 350 nm and about 775 nm and between about 875 nm and about 1075 nm.
- the chemical sensor comprises a shell that further comprises a linker molecule, the linker molecule selected from the group consisting of a thiol group, a sulfide group, a phosphate group, a sulfate group, a cyano group, a piperidine group, an Fmoc group, and a Boc group.
- a linker molecule selected from the group consisting of a thiol group, a sulfide group, a phosphate group, a sulfate group, a cyano group, a piperidine group, an Fmoc group, and a Boc group.
- the chemical sensor comprises a support.
- the support comprises a medium that is permeable to an analyte of interest.
- the chemical sensor has a surface wherein the surface can induce surface enhanced Raman scattering (SERS).
- SERS surface enhanced Raman scattering
- the chemical sensor further comprises at least one detecting molecule, wherein the detecting molecule is bound to the surface.
- the detecting molecule is selected from the group consisting of proteins, peptides, antibodies, antigens, nucleic acids, peptide nucleic acids, sugars, lipids, glycophosphoinositols, and lipopolysaccharides.
- the detecting molecule is an antibody. In another preferred embodiment, the detecting molecule is an antigen.
- the invention provides a chemical sensor further comprising at least one semiconductor quantum dot.
- the semiconductor quantum dot further comprises a linker molecule, the linker molecule selected from the group consisting of a thiol group, a sulfide group, a phosphate group, a sulfate group, a cyano group, a piperidine group, an Fmoc group, and a Boc group.
- the invention provides a chemical sensor comprising at least one semiconductor quantum dot wherein the semiconductor quantum dot further comprises a detecting molecule, wherein the detecting molecule is bound to the semiconductor quantum dot.
- the detecting molecule is selected from the group consisting of proteins, peptides, antibodies, antigens, nucleic acids, peptide nucleic acids, sugars, lipids, glycophosphoinositols, and lipopolysaccharides.
- the detecting molecule is an antibody.
- a more preferred embodiment comprises a chemical sensing device wherein the detecting molecule is an antigen.
- Another embodiment of the invention provides a method for detecting an analyte in a sample using a chemical sensor, the method comprising the steps of: i) providing a sample; ii) providing a semiconductor quantum dot comprising a linker molecule (LM-SQD); iii) conjugating the analyte in the sample with the LM-SQD thereby producing an analyte-LM-SQD conjugate; iv) providing a chemical sensor comprising a plurality of particles, each particle comprising: a core, a shell having at least one surface and having contact with the core and wherein the shell comprises a sulfur-oxygen molecular species, and wherein the particle has been selectively sized using a notch filter and electromagnetic radiation, the electromagnetic radiation having a spectral wavelength of between about 350 nm and about 1075 nm, the shell surface further comprising a detecting molecule; v) incubating the analyte-LM-SQD conjugate with the chemical sensor for
- the invention provides a method for detecting an analyte that is an ovarian cancer marker antibody.
- the detecting molecule in the chemical sensing device is an antigen that binds to an ovarian cancer marker antibody with an affinity (K a ) of at least 10 6 l/mole.
- K a is at least 10 8 l/mole.
- the analyte is a phospholipid.
- the phospholipid is lysophosphatidic acid (LPA).
- the invention provides an optical fiber, the fiber being shaped and adapted to provide a substrate surface for the chemical sensor.
- the fiber has a proximal end and a distal end.
- the fiber is shaped having a D-shape cross-section; in another embodiment the distal end of the fiber is tapered to provide a large substrate surface.
- the fiber has at least two substrate surfaces.
- the invention provides an optical communications device comprising a fiber, a plurality of particles, each particle comprising: a core, a shell having at least one surface and having contact with the core and wherein the shell comprises a sulfur-oxygen molecular species, and wherein the particle has been selectively sized using a notch filter and electromagnetic radiation, the electromagnetic radiation having a spectral wavelength of between about 350 nm and about 1075 nm.
- the optical communications device comprises a fiber, wherein the fiber is selected from the group consisting of ceramics, glasses, polymers, and metal-polymer composites.
- the fiber cross-section is D-shaped.
- the chemical sensor is disposed upon a surface of the fiber.
- the invention also provides a method for synthesizing a chemical sensor comprising gold nanoparticle aggregates, the method comprising the steps of (i) providing one volume (1V) of a solution of 0.1 M HAuCl 4 ; (ii) diluting the solution of HAuCl 4 with Milli-Q water to a final concentration of between 4 ⁇ 10 ⁇ 4 -6 ⁇ 10 ⁇ 4 M HAuCl 4 ; (iii) combining the diluted solution of HAuCl 4 with a 0.1 M solution of Na 2 S to a final concentration of HAuCl 4 of between 4 ⁇ 10 ⁇ 5 -6 ⁇ 10 ⁇ 5 M HAuCl 4 ; (iv) incubating the combined solution for about between 60-120 minutes; and (v) measuring the extended plasmon band of the combined solution until the near-infra-red (NIR) absorption is at a wavelength longer than 600 nm, thereby synthesizing a chemical sensing particle comprising gold nanoparticle aggregates
- the invention also provides a method for coating gold nanoparticle aggregates onto a substrate, the method comprising the steps of (i) providing the gold nanoparticle aggregates as disclosed above; (ii) submerging the gold nanoparticle aggregates in a 5 mM aqueous solution of a tethering molecule, the tethering molecule selected from the group consisting of trimethoxy[3-(methylamino)propyl]silane (APS) and (3-mercaptopropyl)trimethoxy silane (MPS), a compound having a silane terminus and a thiol or amine terminus, and the like; (iii) incubating the gold nanoparticle aggregates with the tethering molecule to allow the gold nanoparticle aggregates to adsorb the tethering molecules; (iv) providing a substrate, wherein the substrate is selected from the group consisting of silicon dioxide, silicon, and the like; (v) sonicating the substrate in contact with a 2% solution of
- the invention also provides a method for creating a chemical sensor with improved sensitivity, the method comprising the steps of: (i) providing the chemical sensing particle comprising gold nanoparticle aggregates as disclosed above; (ii) illuminating the gold nanoparticle aggregates with an amplified femtosecond beam at a flux of approximately 0.1 mJ/cm 2 for 1 hour; (iii) illuminating the gold nanoparticle aggregates using a tunable picosecond laser, thereby creating a chemical sensor with improved sensitivity.
- FIG. 1 shows representative electronic absorption spectra of gold nanoparticle aggregates in water during the growth and aggregation process.
- FIG. 2 shows results from a persistent spectral hole burning experiment using ⁇ 800 nm laser light at 200 ⁇ J/pulse.
- FIG. 3 shows an illustration of how narrowing aggregate size/shape distribution using light is achieved.
- FIG. 4 shows a schematic illustration of how photoluminescence (PL) of an SQD-Ab conjugate is quenched by an MNP-Ag conjugate.
- FIG. 5 shows the results of two SDQ quenching experiments: two SERS spectra of an SQD-Ab (polyclonal donkey anti-goat Ab) conjugate having been quenched by an MNP-Ag conjugate (pink and dark red) and one control SERS spectrum of an SQD without a conjugated Ab (blue).
- SQD-Ab polyclonal donkey anti-goat Ab
- FIG. 6 is an illustration of how a Raman amplifier functions to intensify a photon beam.
- FIG. 7A is an illustration of an exemplary optical fiber having a substrate surface parallel to the axis of the fiber.
- FIG. 8A illustrates an alternative exemplary optical fiber having a single distal substrate surface at an angle to the axis of the fiber.
- FIG. 9 illustrates the path of a photon within the fiber and shown interacting with a nanoparticle aggregate conjugated compound on the substrate surface of the fiber and the resulting SERS photon.
- FIG. 10A illustrates another alternative exemplary optical fiber having two distal substrate surfaces.
- FIG. 11 illustrates the path of photons within the fiber and shown interacting with nanoparticle aggregate conjugated compound on the substrate surfaces of the fiber and the resulting SERS photons.
- FIG. 12 illustrates the distal end of a fiber positioned in proximity to the ends of two additional fibers that transmit the SERS photon to a detector.
- FIG. 13 illustrates the angle of the distal substrate surface to the longitudinal plane of the fiber.
- FIG. 14 shows a representative UV-visible absorption spectrum of silver nanoparticles. The absorption towards the 780 nm region is believed to be sufficient for SERS to occur.
- FIG. 15 shows a Raman spectrum of bulk lysophosphatidic acid crystals (780 nm excitation, 3 mW power) for 16:0 LPA.
- FIG. 16 shows a Raman spectrum of bulk lysophosphatidic acid crystals (780 nm excitation, 3 mW power) for 18:0 LPA.
- FIG. 17 shows SERS spectra of one hundred samples of 10 ⁇ 6 M solutions of 16:0 LPA and 18:0 LPA dried on silver nanoparticles (780 nm excitation, 3 mW power).
- FIG. 18 shows the SERS region between 1050 cm ⁇ 1 -1150 cm ⁇ 1 for 100 ⁇ 10 ⁇ 6 M solutions of 16:0 LPA and 18:0 LPA to show the distinguishable mode at 1097 cm ⁇ 1 and 1101 cm ⁇ 1 (780 nm excitation, 3 mW power).
- FIG. 19 illustrates a schematic of the Raman probe with a D-shaped (or side-polished) fiber coated with SERS substrate on the flat surface. Only the end segment of the fiber (about 1 cm) that is polished is shown. The rest of the unpolished fiber is about 0.5 m.
- FIG. 20 illustrates the intensity distribution as light propagates through the D-shaped fiber covered with a silver film. Area shown is a cross-section parallel to the polished surface and through the center of the fiber core (top view). Inset: contour plot of the intensity distribution in a cross-section perpendicular to the fiber axis (end view). The semi-circle area is the fiber core with the cladding outside the half-circle. The thick black line above the semi-circle represents a 0.1 mm metal particle thin film and above the film (the top blue rectangle) is the air.
- FIG. 21 illustrates a representative SERS spectra of rhodamine 6G on silver nanoparticles dried onto a D-shaped fiber collected with excitation laser incident to fiber surface (A) and coupled into the fiber (B).
- a particle includes a plurality of such particles
- a reference to “a surface” is a reference to one or more surfaces and equivalents thereof, and so forth.
- GNAs novel gold nanoparticle aggregates
- SERS surface enhanced Raman scattering
- these GNAs have unique surface properties due to sulfur species on their surface that not only causes the aggregation in the first place but also provides a strong driving force for binding with chemical and biological molecules with high affinity for sulfur.
- the particles can have a size range of about between 60 and 200 nm.
- FIG. 1 shows some representative electronic absorption spectra of the GNAs in water during the growth process.
- the spectrometer used limits the measurements to about 850 nm in the near IR.
- the strong near IR band is clearly visible in the spectra.
- a white light source with a particular wavelength blocked by an optical notch filter is used to irradiate a sample of GNA having a broad distribution of aggregate sizes and shapes. All the aggregates can be either destroyed and/or converted into the aggregates that absorb at the blocked wavelength. This can significantly reduce the size and shape distribution of the aggregates. Only aggregates that absorb (on resonance) with the blocked wavelength will remain and such aggregate samples are stable. This principle can work for many other metal nanoparticle aggregates such as silver, Pt, and Pd, etc. The size/shape-narrowed aggregates are useful for many applications such as SERS or can be used as an optical filter with a fairly narrow bandwidth. The aggregates can further be patterned onto a solid substrate and used for any application that can benefit from narrow distributed metal nanoparticle aggregates.
- FIG. 2 shows the results of a persistent spectral hole burning experiment using ⁇ 800 nm laser light at 200 ⁇ J/pulse. Trace a) is prior to laser irradiation. Trace b) is after 2.5 hours of hole burning. A hole is clearly seen in trace b) as well as a growth and shift of the maximum absorbance to bluer wavelengths.
- the SERS enhancement has been observed as being at about one-billion-fold (10 9 ) that is approximately three to four orders of magnitude greater than that disclosed in the prior art. Such an increase in enhancement therefore results in a reagent with greater sensitivity than other systems.
- the market mainly comprises fiber-optical communications devices that are used to transmit information using photons instead of electrons.
- the devices comprise light amplifiers that retain the intensity of light as it travels through fiber optic networks.
- Light amplifiers are used to increase the intensity of weak light signals as they travel through long distances of fiber optic networks.
- the most commonly used form of light amplification is the Raman amplifier because it has proven to be the most efficient. This technique increases the frequency of transmitted light signals within a fiber optic network to prevent a loss of transferred data. This market has not currently been tapped in notch filters.
- Raman spectroscopy is a powerful optical technique for detecting and analyzing molecules. Its principle is based on detecting light scattered off a molecule that is shifted in energy with respect to the incident light. The shift, called Raman shift, is characteristic of individual molecules, reflecting their vibrational frequencies that are like figure prints of molecules. As a result, the key advantage of Raman spectroscopy is its molecular specificity while its main limitation is the small signal due to low quantum yield of Raman scattering.
- One way to enhance the Raman signal is to tune the excitation wavelength to be on resonance with an electronic transition, so called resonance Raman scattering. This can usually produce an enhancement on the order of 10 2 -10 3 .
- the GNAs can be suitable for SERS detection and analysis of a large number of molecules, including, but not limited to, proteins, DNA, explosives, chemical and biological warfare agents, toxins, and even virus and biological cells.
- the GNAs are SERS active for amino acids and DNA bases as well as antibodies for cancer detection.
- the possibility of narrowing the optical absorption of the GNAs for SERS is an important added advantage.
- SERS can also be developed into a molecular imaging technique for biomedical and other applications. Exciting Raman imaging equipment may be usable for SERS imaging. SERS can provide an enhanced signal and thereby significantly shortened data acquisition time, making the technique practically useful for medical or other commercial and industrial applications including, but not limited to, chip inspection or chemical monitoring.
- Fluorescent nanoparticles semiconductor quantum dots, SQDs
- SQDs semiconductor quantum dots
- GNAs of the invention can be used to detect an analyte.
- an analyte can be, for example, but not limited to, an antigen, an antibody, a biochemical metabolite, an organic compound, a compound or element having biological activity, or the like.
- the GNAs of the invention can be used in a novel dual optical scheme for sensitive and selective detection of antigens and is illustrated in FIG. 4 .
- the technique is based on detection of photoluminescence from SQDs with antibody (Ab) attached and SERS (surface enhanced Raman scattering) spectra of antigen (Ag) attached to the GNAs that comprise metal nanoparticles (MNP).
- SERS spectrum is a measure of the Raman spectrum of the Ag that can be significantly enhanced by a metal nanoparticle.
- the Raman spectrum similar to an infra-red (IR) spectrum, is characteristic of specific molecules due to the unique set of vibrational frequencies of each molecule.
- the distance will be dependent on the sizes of the SQD, GNA, Ag, and Ab, the length of a linker molecule (LM) between the SQD and the Ag (or alternatively, between the SQD and the Ab, between the GNA and Ab, or between the GNA and Ag), as well as on their relative binding configuration.
- LM linker molecule
- FIG. 5 shows two representative SERS spectra where the reproducible peaks can be attributed to the Ab. To our best knowledge, this is the first demonstration of SERS detection of Ab. Since Raman or SERS spectrum is extremely sensitive to the structure, configuration and environment of a molecule, we anticipate that the SERS spectrum of an Ab can change upon interaction with its Ag.
- the proposed scheme offers a novel technique for detecting antigen with high sensitivity (offered by both PL and SERS) and specificity (offered by both SERS and Ag-Ab interaction).
- a laser wavelength that is on resonance with absorption of the QD usually in the near UV and visible region
- the Ag can be replaced by a second Ab, the second Ab being specific for binding the first Ab.
- the second antibody can be from the same animal species as the first Ab, or can be from another animal species.
- Such first and second Abs are well known to those in the art and can be raised in and isolated from an animal such as, but not limited to, a rabbit, a human, a mouse, a rat, a monkey, an ape, a goat, a sheep, a cow, a pig, a donkey, a horse, a guinea pig, a whale, a wombat, a platypus, or the like.
- SERS is also useful for detecting other cancer biomarkers that can interact or bind to the GNA surface.
- LPL lysophospholipids
- a favorable interaction between LPL molecules with GNA through electrostatic interaction can occur at the appropriate pH.
- the strongest interaction with GNA occurs at the isoelectrostatic pH, i.e. pH at which the GNA has equal number of positive and negative charges.
- the pH is varied to adjust the charge on the GNA to determine the optimal pH or charge for strong interaction with LPL.
- the Ag and/or the Ab can be conjugated to the QD or GNA using a linker molecule (LM).
- LM linker molecule
- a decrease in fluorescence can indicate the presence of the antibody for that particular antigen to which the fluorescing QDs have been attached.
- LM linker molecule
- a wide array of antibodies can be detected. This can allow for the rapid detection of cancers or diseases that currently can take days or weeks to diagnose.
- the scheme can work as well if antibody is attached to a fluorescent QD and the respective antigen to a metal nanoparticle.
- Metal particles have no florescence with visible excitation.
- the fluorescence quenching by metal nanoparticles can be more effective than quenching by larger QDs. This approach is sensitive and specific.
- the distance between the metal nanoparticle and QD is important for this to work (for example, the distance can be less than 2 nm). The interaction between the two components can be adjusted to achieve the maximum quenching effect.
- LPA lysophosphatidic acid
- Lysophosphatidic acid originally known for its role as an intermediate in intracellular lipid metabolism, has now been recognized as an important multifunctional biological mediator that can elicit cellular responses including mitogenic and antimitogenic effects on the cell cycle, actin skeleton regulation, and cellular motility (see Tigyi et al. (1994) Proc. Nat. Acad. Sci. 91: 1908-1912; van Corven et al. (1989) Cell 59: 45-54; Ridley and Hall (1992) Cell 70: 389-399; and Zhou et al (1995) J. Biol. Chem. 270: 25549-25556).
- LPA LPA-induced cell proliferation, migration and survival implicates it in the initiation and progression of malignant disease, and has been proposed as a sensitive biomarker for ovarian cancer (see Xu et al (1998) JAMA 280: 719-723; Mills and Moolenaar (2003) Nature Reviews 3: 582-591; Fang et al (2004) J. Biol. Chem. 279: 9653-9661; and Sutphen et al (2004) Cancer Epidemiol. Biomark. Prev. 13: 1185-1191).
- the detection of LPA has been conducted using chromatography and mass spectroscopy assays that require a partial purification of the samples using thin layer chromatography (TLC) prior to analysis.
- TLC thin layer chromatography
- this method is effective, an underestimation of LPA concentration can result during the recovery process due in part to the varying mobility of the LPA salts (free acid, sodium and calcium salts) when subjected to chromatography by TLC.
- the low stability of LPA also calls for fast and sensitive detection techniques.
- SERS surface-enhanced Raman scattering
- SERS Raman spectrum of semiconductor nanoparticles
- QDs semiconductor nanoparticles
- SERS as an enhanced Raman technique for measuring Raman for semiconductor nanoparticles have not been reported before.
- the surface chemistry of the metal nanoparticles and the semiconductor QDs must be compatible for this to work.
- the sulfur species on the surface of the GNAs are ideal for II-VI SQDs to bind, enabling SERS detection of the SQDs. This provides a powerful method for detecting and analyzing semiconductor nanoparticles.
- Raman amplifiers have been used to amplify signal in optical communications (see, for example, FIG. 6 ). SERS can provide more amplification than normal Raman amplifiers. By doping MNPs, for example GNAs, into glass or polymer fibers, Raman scattering from the glass or polymer matrix can be used to amplify optical signal with the proper wavelength.
- MNPs for example GNAs
- Proteins or portions thereof may be produced not only by recombinant methods, but also by using chemical methods well known in the art.
- Solid phase peptide synthesis may be carried out in a batchwise or continuous flow process which sequentially adds ⁇ -amino- and side chain-protected amino acid residues to an insoluble polymeric support via a linker molecule.
- a linker molecule such as methylamine-derivatized polyethylene glycol is attached to poly(styrene-co-divinylbenzene) to form the support resin.
- the amino acid residues are N- ⁇ -protected by acid labile Boc (t-butyloxycarbonyl) or base-labile Fmoc (9-fluorenylmethoxycarbonyl).
- the carboxyl group of the protected amino acid is coupled to the amine of the linker group to anchor the residue to the solid phase support resin.
- Trifluoroacetic acid or piperidine are used to remove the protecting group in the case of Boc or Fmoc, respectively.
- Each additional amino acid is added to the anchored residue using a coupling agent or pre-activated amino acid derivative, and the resin is washed.
- the full-length peptide is synthesized by sequential deprotection, coupling of derivatized amino acids, and washing with dichloromethane and/or N,N-dimethylformamide.
- the peptide is cleaved between the peptide carboxy terminus and the linker group to yield a peptide acid or amide.
- Automated synthesis may also be carried out on machines such as the ABI 431A peptide synthesizer (ABI).
- a protein or portion thereof may be purified by preparative high performance liquid chromatography and its composition confirmed by amino acid analysis or by sequencing (Creighton (1984) Proteins, Structures and Molecular Properties, W H Freeman, New York N.Y.).
- a purified antigen may be used to produce antibodies or to screen libraries of pharmaceutical agents to identify those that specifically bind an antigen.
- Antibodies to an antigen may also be generated using methods that are well known in the art. Such antibodies may include, but are not limited to, polyclonal, monoclonal, chimeric, and single chain antibodies, Fab fragments, and fragments produced by a Fab expression library. Neutralizing antibodies (i.e., those which inhibit dimer formation) are especially preferred for therapeutic use.
- various hosts including goats, rabbits, rats, mice, humans, and others may be immunized by injection with an antigen or with any fragment or oligopeptide thereof that has immunogenic properties. Rats and mice are preferred hosts for downstream applications involving monoclonal antibody production.
- various adjuvants may be used to increase immunological response.
- adjuvants include, but are not limited to, Freund's, mineral gels such as aluminum hydroxide, and surface-active substances such as lysolecithin, pluronic polyols, polyanions, peptides, oil emulsions, keyhole limpet hemacyanin (KLH), and dinitrophenol.
- BCG Bacilli Calmette-Guerin
- Corynebacterium parvum are especially preferable.
- the oligopeptides, peptides, or fragments used to induce antibodies to an antigen have an amino acid sequence consisting of at least about 5 amino acids, and, more preferably, of at least about 14 amino acids. It is also preferable that these oligopeptides, peptides, or fragments are identical to a portion of the amino acid sequence of the natural protein and contain the entire amino acid sequence of a small, naturally occurring molecule. Short stretches of antigen amino acids may be fused with those of another protein, such as KLH, and antibodies to the chimeric molecule may be produced.
- Monoclonal antibodies to an antigen may be prepared using any technique that provides for the production of antibody molecules by continuous cell lines in culture. These include, but are not limited to, the hybridoma technique, the human B-cell hybridoma technique, and the EBV-hybridoma technique. (See, for example, Kohler et al. (1975) Nature 256: 495-497; Kozbor et al. (1985) J. Immunol. Methods 81: 31-42; Cote et al. (1983) Proc. Natl. Acad. Sci. 80: 2026-2030; and Cole et al. (1984) Mol. Cell Biol. 62: 109-120.)
- chimeric antibodies such as the splicing of mouse antibody genes to human antibody genes to obtain a molecule with appropriate antigen specificity and biological activity, can be used.
- techniques developed for the production of “chimeric antibodies” such as the splicing of mouse antibody genes to human antibody genes to obtain a molecule with appropriate antigen specificity and biological activity, can be used.
- techniques described for the production of single chain antibodies may be adapted, using methods known in the art, to produce antigen-specific single chain antibodies.
- Antibodies with related specificity, but of distinct idiotypic composition may be generated by chain shuffling from random combinatorial immunoglobulin libraries. (See, for example, Burton (1991) Proc. Natl. Acad. Sci. 88: 10134-10137.)
- Antibodies may also be produced by inducing in vivo production in the lymphocyte population or by screening immunoglobulin libraries or panels of highly specific binding reagents as disclosed in the literature. (See, for example, Orlandi et al. (1989) Proc. Natl. Acad. Sci. 86: 3833-3837; and Winter et al. (1991) Nature 349: 293-299.)
- Antibody fragments that contain specific binding sites for an antigen may also be generated.
- fragments include, but are not limited to, F(ab′)2 fragments produced by pepsin digestion of the antibody molecule and Fab fragments generated by reducing the disulfide bridges of the F(ab′)2 fragments.
- Fab expression libraries may be constructed to allow rapid and easy identification of monoclonal Fab fragments with the desired specificity. (See, for example, Huse et al. (1989) Science 246: 1275-1281.)
- immunoassays may be used for screening to identify antibodies having the desired specificity and minimal cross-reactivity.
- Numerous protocols for competitive binding or immunoradiometric assays using either polyclonal or monoclonal antibodies with established specificities are well known in the art.
- Such immunoassays typically involve the measurement of complex formation between an antigen and its specific antibody.
- a two-site, monoclonal-based immunoassay utilizing monoclonal antibodies reactive to two non-interfering antigen epitopes is preferred, but a competitive binding assay may also be employed. (Maddox, supra.)
- K a association constant
- High-affinity antibody preparations with K a ranging from about 10 9 to 10 12 l/mole are preferred for use in immunoassays in which the antigen-antibody complex must withstand rigorous manipulations.
- Low-affinity antibody preparations with K a ranging from about 10 6 to 10 7 l/mole are preferred for use in immunopurification and similar procedures which ultimately require dissociation of antigen, preferably in active form, from the antibody.
- polyclonal antibody preparations may be further evaluated to determine the quality and suitability of such preparations for certain downstream applications.
- a polyclonal antibody preparation containing at least 1-2 mg specific antibody.ml ⁇ 1 , preferably 5-10 mg specific antibody.ml ⁇ 1 is preferred for use in procedures requiring precipitation of antigen-antibody complexes.
- Procedures for evaluating antibody specificity, titer, and avidity, and guidelines for antibody quality and usage in various applications, are generally available. (See, for example, Catty, supra, and Coligan et al. supra.)
- oligopeptide, peptide, or portion of protein used to induce antibodies should consist of at least about five amino acids, more preferably ten amino acids, which are identical to a portion of the natural protein. Oligopeptides may be fused with proteins such as KLH in order to produce antibodies to the chimeric molecule.
- Monoclonal antibodies may be prepared using any technique that provides for the production of antibodies by continuous cell lines in culture. These include, but are not limited to, the hybridoma technique, the human B-cell hybridoma technique, and the EBV-hybridoma technique. (See, for example, Kohler et al. (1975) Nature 256:495-497; Kozbor et al. (1985) J. Immunol. Methods 81:31-42; Cote et al. (1983) Proc. Natl. Acad. Sci. 80:2026-2030; and Cole et al. (1984) Mol. Cell. Biol. 62: 109-120.)
- antibody fragments that contain specific binding sites for epitopes of the protein may also be generated.
- fragments include, but are not limited to, F(ab′)2 fragments produced by pepsin digestion of the antibody molecule and Fab fragments generated by reducing the disulfide bridges of the F(ab)2 fragments.
- Fab expression libraries may be constructed to allow rapid and easy identification of monoclonal Fab fragments with the desired specificity. (See, for example, Huse et al. (1989) Science 246: 1275-1281.)
- the antigen may be used in screening assays of phagemid or B-lymphocyte immunoglobulin libraries to identify antibodies having the desired specificity.
- Numerous protocols for competitive binding or immunoassays using either polyclonal or monoclonal antibodies with established specificities are well known in the art. Such immunoassays typically involve the measurement of complex formation between the protein and its specific antibody.
- a two-site, monoclonal-based immunoassay utilizing monoclonal antibodies reactive to two non-interfering epitopes is preferred, but a competitive binding assay may also be employed (Pound (1998) Immunochemical Protocols, Humana Press, Totowa N.J.).
- an antibody can be substituted by, for example, a chimeric protein that comprises a portion or fragment of a T-cell receptor (TCR).
- TCRs have an immunoglobulin domain that binds a cell-surface antigen comprising a host or a non-host molecule.
- Such molecules can be of viral origin or can be a particular cancer marker protein.
- the chimeric protein can also comprise a soluble protein (i.e. present in a bodily fluid or the cell cytoplasm) or a cell membrane-associated protein (such as a ligand receptor, an ion channel, or a molecule involved in signal transduction.
- Metal nanoparticles are currently studied for a wide variety of biomedical applications including contrast imaging, ultrasonic imaging, thermal destruction of specific cancer cells, and laser tissue welding. All applications of this type rely on the optical and physical properties associated with metal nanoparticles, nominally of gold. Much of this work has focused on gold nanoshells due to their near IR optical absorption where tissue transmission is at its peak, making in-vivo applications feasible. This gold nanoparticle aggregate system possesses these same optical features with multiple advantages. While nanoshells can be tuned to absorb in a particular region, their absorption is inhomogenously broad and cannot be narrowed without significant purification. Therefore a significant percentage of nanoshells will be functionally useless at a given wavelength. Gold aggregates on the other hand can be tuned to have a very narrow absorption through the optical hole burning technique. With the absorption tuned to a given wavelength all aggregates will be utilized making them significantly more efficient for any of the above applications.
- the nanoparticle aggregates are selectively attached to cancer cells in a tumor by a passive mechanism that has been termed an “enhanced permeability and retention effect”.
- the tumor mass is then illuminated with near IR laser light which passes harmlessly through the tissue, but is absorbed strongly by the aggregates, causing them to heat drastically, killing only the cancerous cells.
- the nanoparticle aggregates can be used to detect specific compounds that may be at very low levels in a sample.
- a sample can be blood, urine, saliva, lung lavage, gastric fluid, lymphatic fluid, any other body fluid, or the like.
- the sample can be a sample of water or other aqueous medium, such as water from a spring, a stream, a river, a pond, a lake, a sea, or an ocean.
- the sample can be a geological sample such as from a geothermal spring, a lava evaporate or exudate, a hydrocarbon, or from an abyssal trench; a plant sample such as from the xylem or phloem of a stalk or trunk; a sample from a fluid in a man-made structure such as concrete, cement, aggregate, or the like; a sample of fluid from a piece of machinery such as an engine, motor, compressor, or the like.
- a geological sample such as from a geothermal spring, a lava evaporate or exudate, a hydrocarbon, or from an abyssal trench
- a plant sample such as from the xylem or phloem of a stalk or trunk
- a sample from a fluid in a man-made structure such as concrete, cement, aggregate, or the like
- a sample of fluid from a piece of machinery such as an engine, motor, compressor, or the like.
- the nanoparticle aggregates can be conjugated with antibody, the antibody having been synthesized to bind a specific compound.
- a specific compound can be a protein, a fatty acid, a carbohydrate, an organic compound based upon a benzene ring structure, an organic compound based upon a short chain hydrocarbon, a medium chain hydrocarbon or a long chain hydrocarbon.
- the specific compound can be modified with a reactive group.
- reactive groups are well known to those of skill in the art and can include phosphate groups, methyl groups, hydroxyl groups, sulphate groups, acetyl groups, or the like.
- the nanoparticle aggregate-antibody conjugate complex has an altered SERS profile when the specific compound binds to the complex.
- the complex can be applied and incorporated onto a substrate surface of an optical fiber as disclosed herein.
- the exterior surface of the fiber comprises a compound that reflects photons. Such compounds are well known to those in the fiberoptic arts.
- the optical fiber has a proximal end or proximal section and a distal end or distal section.
- the distal end of a conventional fiber has a circular cross-section.
- a modified substrate surface can be created to create a substrate surface having an area larger than that of the distal end.
- the substrate surface of the fiber is created by removing a distal portion of the fiber section thereby creating a fiber with a distal end cross-section that is different from the distal end of the original fiber.
- the cross-section can be D-shaped, diamond-shaped, triangular, oval, or another non-symmetrical shape. Removing a portion of the fiber results in substrate surface with a larger surface area than the surface area of the original end of the fiber.
- the resulting substrate surface can have a surface area that is up to at least about 8,000-fold larger than the distal end surface of the original fiber.
- the diameter of the fiber can be from between about 0.01 ⁇ m to about 10 ⁇ m. In one alternative, the diameter is from between about 0.1 ⁇ m to about 1 ⁇ m. In another alternative, the diameter is between about 0.2 ⁇ m to about 8 ⁇ m.
- the complex is applied and incorporated onto the substrate surface and light is directed longitudinally through the fiber.
- the light can be coherent and/or non-coherent.
- the light interacts with the nanoparticle aggregate-antibody conjugate complex and a resulting SERS profile can be compared with a SERS profile from the nanoparticle aggregate-antibody conjugate complex that is bound with a known amount of specific compound.
- the SERS radiation is detected using a photon detector suitably disposed to detect the SERS radiation.
- the detector can be disposed at or near the substrate surface of the fiber at the distal end or distal section of the fiber, at or near the proximal end or proximal section of the fiber, or at another position as disclosed herein.
- the fiber can have one or more such substrate surfaces.
- the second substrate surface can reflect the SERS signal from the first substrate surface to the detector longitudinally along the length of the fiber, resulting in a markedly improved amplification of the SERS signal.
- the first substrate surface can reflect a SERS signal from the second substrate surface to the detector.
- At least one additional optical fiber can be positioned in proximity to the distal end or distal section of the fiber.
- the end of the additional fiber can have the same shape as the shape of the distal end or distal section of the fiber, such that SERS radiation emitted from the fiber is conducted through the additional fiber to a detector.
- Two additional fibers can be used in parallel where there are two new substrate surface s on the fiber.
- the optical fiber can additionally have a non-uniform diameter, for example, the distal end having a cross-section perpendicular to the longitudinal plane that is larger in magnitude than a cross-section of the proximal end.
- a shape can further increase the amount of SERS radiation produced by a photon source.
- the optical fiber can be made using glass, ceramics, or the like; or a polymeric compound such as cyclic olefin polymer (COP), polysulfone (for example, UDEL and RADEL resins), fluorinated terpolymers (such as those synthesized from tertafluoroethylene, hexafluoropropylene, and vinylidene fluoride), polycarbonate, polyacrylate, polystryrene, or the like.
- COP cyclic olefin polymer
- polysulfone for example, UDEL and RADEL resins
- fluorinated terpolymers such as those synthesized from tertafluoroethylene, hexafluoropropylene, and vinylidene fluoride
- polycarbonate polyacrylate
- polystryrene or the like.
- the surface of the substrate surface ( 2 ) of the fiber ( 1 ) is at an angle ⁇ ( 7 ) to the longitudinal plane ( 8 ) of the fiber.
- the angle ⁇ is between 15° and 75°; preferably between 15° and 65°; more preferably between 15° and 45°; and most preferably between 15° and 35°. In one example, the angle ⁇ is 22.5°.
- the optimal preferable angle can be determined empirically to find the optimal angle for back-scattering of the SERS radiation.
- One of skill in the art can readily determine which angle ⁇ is optimal using data collected from experimentation as described above and knowledge of the composition of the fiber. It is well known in the art that different compositions have different refractive indices and one of skill in that art would know that different compositions will have a particular optimal refractive index. One of skill in the art would also know that it is not always necessary to create a fiber having a distal end section having a substrate surface at the optimal angle ⁇ to the plane of the fiber since the nanoparticle aggregate-antibody conjugate complex can have different effects upon the refractivity of a fiber compound. It would require relatively little experimentation by one of skill in the art to determine the optimal preferable angle ⁇ .
- the SERS radiation can be further enhanced approximately 4-5-fold if an electrical field of a few Volts per centimeter (V/cm) is applied across the fiber, approximately perpendicular to the substrate surface.
- the potential difference can be maintained through an electrically conducting solution.
- the electrically conducting solution can be aqueous or non-aqueous but should not quench SERS radiation to the extent that the SERS enhancement due to the electrical field is quenched by the electrically conducting solution.
- FIGS. 7 through 12 Examples of different optical fiber ends are illustrated in FIGS. 7 through 12 .
- FIG. 7A illustrates a cylindrical fiber ( 1 ) having an exterior surface ( 3 ) and having a longitudinal portion removed from the distal section of the fiber thereby creating a substrate surface ( 2 ).
- FIG. 7B shows a cross-section of the distal section.
- FIG. 8A illustrates an alternative distal section whereby a longitudinal portion is removed from the fiber at an included plane to the fiber resulting in a tapered distal end of the fiber.
- FIGS. 8B , 8 C, and 8 D illustrate three cross-sections of the distal section at different positions along the length of the fiber.
- FIG. 9 illustrates the path of a photon ( 4 ) from a photon source and the path of a SERS photon ( 5 ) from the substrate surface of the fiber to a detector ( 6 ).
- FIG. 10A illustrates another alternative distal section whereby two longitudinal portions are removed from the fiber resulting in a tapered distal end of the fiber.
- FIGS. 10B , 10 C, and 10 D illustrate three cross-sections of the distal section at different positions along the length of the fiber.
- FIG. 11 illustrates the path of a photon ( 4 ) from the photon source and the path of a SERS photon ( 5 ) from the substrate surface ( 2 ) of the fiber to a detector ( 6 ).
- FIG. 12 illustrates the distal end of a fiber positioned in proximity to the ends of two additional fibers that transmit the SERS photon to a detector.
- FIG. 13 illustrates the angle between the substrate surface ( 2 ) and the longitudinal plane ( 8 ) or axis of the fiber.
- the nanoparticle aggregates can be formed and shaped into a desired shape, such as a sphere, a cylinder, a rod, a cone, a pyramid, or other shape, not limited to regular shapes, and deposited upon a substrate at a desired density using means well known t to hose of skill in the art. (See, for example, Fan et al. (2005) J. Vac. Sci. Technol. 8: 947-953; Chaney et al. (2005) Appl. Phys. Lett. 87: pub. no. 031908.)
- the synthesis of the gold nanoparticle aggregates was performed as follows: 400-600 ul of a 0.02 M HAuCl 4 stock solution was diluted to 4 ⁇ 10 ⁇ 4 -6 ⁇ 10 ⁇ 4 M with Milli-Q water in glassware cleaned in aquaregia and rinsed with Milli-Q water to avoid contamination. To this, 40-60 ⁇ l of a 0.1 M solution of Na 2 S that has been aged for 2-3 months was added. After approximately 60-120 minutes, the color changed from a straw yellow to deep purple with the extended plasmon band (EPB) growing in between 600-1000 nm, indicating reaction completion. The aggregate formation was signified by strong near-infra-red (NIR) absorption at wavelengths longer than 600 nm.
- NIR near-infra-red
- This reaction is also performed with sodium thiosulfate (Na 2 S 2 O 3 ) by replacing 1:1 the sodium sulfide solution, however, while these particles are optically identical to those that are sodium sulfide generated, they work poorly for SERS and should only be used for non detection applications.
- the coating of gold nanoparticle aggregates onto a substrate/fiber was performed in two ways. First, by spin coating or drop casting a dilute solution of the aggregates onto the substrate. This yields a relatively thick film, however, it is not as stable as is necessary for many applications.
- the second method utilizes a tethering molecule, in this case trimethoxy[3-(methylamino)propyl]silane (APS).
- APS trimethoxy[3-(methylamino)propyl]silane
- the substrate was cleaned prior to the silanization step by sonication in 2% solution of HELLMANEX or other surfactant, followed by 18 m ⁇ water.
- the gold nanoparticle aggregates were then submerged in a 5 mM aqueous solution of APS to deposit the tethering molecules. After 1-2 minutes the substrate was rinsed with water, dried under nitrogen, and 40 ⁇ l of the aggregate solution was placed on the surface. After several seconds exposed to the solution, it was blown dry with nitrogen. This provided a significantly thinner film than those made by spin or drop casting, however, it was extremely stable and robust under use. This film was made to near monolayer coverage by increasing the substrate exposure time to the APS and aggregate solutions to approximately 1 hour. APS was obtained from Sigma-Aldrich.
- the extended plasmon band of the gold nanoparticle aggregates were tuned and narrowed via a regeneratively amplified, mode locked femtosecond Ti-sapphire laser system. This was done by illuminating the sample with the amplified femtosecond beam at a flux of approximately 0.1 mJ/cm 2 . After approximately 1 hour, a deep, broad hole was burned in the absorption spectrum at near 800 nm while absorption to the blue drastically increased.
- a tunable picosecond laser In order to tune the band to one particular wavelength a tunable picosecond laser is required. Due to the broad spectral linewidth of the femtosecond pulses it is impossible to completely narrow the extended plasmon band (EPB). By using the spectrally narrow picosecond pulses it is possible to selectively destroy the EPB to the blue and red of the desired excitation wavelength, enhancing the absorption more than two fold.
- Samples for single particle experiments were prepared by immobilizing the GNAs or semiconductor quantum dots (SQD) on glass coverslips with trimethoxy[3-(methylamino)propyl]silane (APS). Coverslips were cleaned prior to the silanization step by sonication in 2% solution of Hellmanex, followed by 18 M ⁇ water. They were then submerged in 5 mM aqueous solution of APS to deposit the tethering molecules. After 1-2 minutes the coverslips were rinsed with water, dried under nitrogen, and 40 ⁇ l of the aggregate or SQD solution was placed on one surface. After several seconds exposed to the solution, it was blown dry with nitrogen.
- SQD semiconductor quantum dots
- Single particle experiments were performed on a custom designed confocal microscope built onto an inverted fluorescence microscope (Axiovert 100, Carl Zeiss, Inc., Thornwood N.Y.).
- a helium-neon or Argon ion laser depending on desired excitation wavelength was coupled into the back port of the microscope and directed into a high numerical aperture objective (Apochromat 100 ⁇ , 1.4 NA) that focused the light onto the sample surface.
- the sample was then raster scanned across the focused laser to generate an image using a commercially available piezoelectric scanner (Physik Instrumente, Auburn Mass.) and control electronics (Digital Instruments (Veeco Instruments Inc.) Woodbury N.Y.).
- the Raman scattered light or fluorescence was collected with the same objective used for excitation and focused onto a confocal aperture.
- the Rayleigh scattered light was then removed using a holographic notch filter (Kaiser Optical Systems, Inc., Ann Arbor Mich.) and the remaining scattered light was focused onto an avalanche photodiode (EG&G (ClTY STATE)).
- a holographic notch filter Kerman Optical Systems, Inc., Ann Arbor Mich.
- avalanche photodiode avalanche photodiode
- a nanoparticle aggregate or QD was located, it was centered on the focused laser and the Raman scattering was directed into a spectrograph (Acton Instruments, Acton Mass.) that dispersed the light onto a liquid nitrogen cooled CCD camera (Princeton Instruments, Trenton N.J.). Typically six spectra (30 seconds each) were averaged.
- Lysophosphatidic acid originally known for its role as an intermediate in intracellular lipid metabolism, has now been recognized as an important multifunctional biological mediator that can elicit cellular responses including mitogenic and antimitogenic effects on the cell cycle, actin skeleton regulation, and cellular motility.
- LPA Lysophosphatidic acid
- the involvement of LPA in inducing cell proliferation, migration and survival implicates it in the initiation and progression of malignant disease, and has been proposed as a sensitive biomarker for ovarian cancer.
- the detection of LPA has been conducted using chromatography and mass spectroscopy assays that require a partial purification of the samples using thin layer chromatography (TLC) prior to analysis.
- TLC thin layer chromatography
- this method is effective, an underestimation of LPA levels can result during the recovery process due in part to the varying mobility of the LPA salts (free acid, sodium and calcium salts) when subjected to chromatography by TLC.
- the low stability of LPA also calls for fast and sensitive detection techniques.
- SERS surface-enhanced Raman scattering
- Powder samples of 16:0 LPA (1-Palmitoyl-2-hydroxy-sn-glycero-3-phosphate(sodium salt)) and 18:0 LPA (1-Stearoyl-2-hydroxy-sn-glycero-3-phosphate(sodium salt)) were purchased from Avanti Polar Lipids, Inc. Silver nitrate and sodium citrate were purchased from Sigma Aldrich (St Louis Mo.).
- Raman spectra were obtained using a Renishaw micro-Raman setup with a 50 ⁇ objective lens and 780 nm excitation laser at 3 mW.
- Silver nanoparticles were prepared using a synthesis from Lee and Meisel using silver nitrate as the metal precursor and a sodium citrate reducing agent (Lee and Meisel (1982) J. Phys. Chem. 86: 3391-3395). Formation of the silver nanoparticles was monitored using UV-visible spectroscopy using a HP 8452A spectrometer with 2 nm resolution. This nanoparticle solution was then concentrated by a factor of 10 via centrifugation prior to application. For the SERS experiment, 2 ⁇ l drops of the concentrated silver nanoparticles were placed on a glass slide and allowed to dry. Its Raman signal was obtained with one accumulation of a 30 second scan.
- FIG. 14 presents the UV-vis absorption spectrum of the silver nanoparticles used in this experiment.
- the surface plasmon band of these particles peaks near 400 nm, and contains very weak absorption around 780 nm, possibly due to some nanoparticle aggregation.
- resonance absorption of the metal nanoparticle substrate with the incident wavelength is essential (Schwartzberg et al. (2004) supra).
- the band at 889 cm ⁇ 1 is representative of methylene rocking, and the 1294 cm ⁇ 1 band is typical of methylene twisting.
- the C—C skeletal stretching vibrations appeared between 1060 cm ⁇ 1 -1130 cm ⁇ 1 . In this region, information about the conformation of the carbon chain can also be obtained.
- the bands observed around 1060 cm ⁇ 1 and 1130 cm ⁇ 1 are characteristic of trans bonded carbon and the band observed around 1100 cm ⁇ 1 denotes the vibration of a gauche bonded chain.
- the analysis of the spectra obtained for these LPA samples compared well to Raman spectra of various lipids that have been previously analyzed (Dai et al (2005) Colloids and Surfaces B 42: 21-28; Krafft et al.
- FIG. 17 presents the SERS spectra of the two LPA samples that were dried on the silver nanoparticles after subtracting the background signal of the dried nanoparticle solution. Attempts to obtain the Raman spectra of dried samples of LPA solutions without any silver present resulted in no signal, indicating that the presence of the silver enhanced the LPA Raman signal and made the detection of low concentrations possible. As expected, the bands of the acyl chain were enhanced using this technique with little to no shift from their bulk Raman positions.
- the SERS signal of the 16:0 LPA maintained its peaks of 889 cm ⁇ 1 , 1097 cm ⁇ 1 , 1128 cm ⁇ 1 , and 1294 cm ⁇ 1
- 18:0 LPA maintained its peaks of 889 cm ⁇ 1 , 1101 cm ⁇ 1 , 1128 cm ⁇ , and 1294 cm ⁇ 1
- FIG. 18 shows the region between 1050 cm ⁇ 1 -1130 cm ⁇ 1 , demonstrating the ability of this procedure to detect the gauche peak that allows the acyl chains of the LPA samples to be distinguished from each other is clearly observed.
- the relative enhancement of a given mode implies the preferred orientation of the adsorbate to the surface of the metal.
- enhancement of a given mode is best when it is closest to the surface of the metal. Comparing the band intensities of the SERS spectrum of either LPA sample to its respective bulk spectrum shows that the two are quite similar (see Table 1). In other words, the intensity distribution of the SERS modes of 16:0 LPA exhibited a similar pattern of its bulk spectrum. The same pattern was observed for the 18:0 samples. This implied that no strong attraction was occurring between the nanoparticle surface and functional groups on the molecule to promote a specific orientation of the adsorbate.
- SC2020 Santa Cruz Biotechnology Santa Cruz Calif.
- SC1616 Santa Cruz Biotechnology Santa Cruz Calif.
- SC2020 was obtained at a concentration of 400 ⁇ g/ml and diluted by a factor of two with 20 mM HEPES buffer (pH 7.4). This solution was mixed equal volume with a GNP solution that was also diluted by a factor of two with 20 mM HEPES buffer. After twenty minutes of interaction, a SERS spectrum was obtained.
- a murine monoclonal antibody raised against the CA125 ovarian cancer marker (OC125; Bast et al. (1981) J. Clin. Invest. 68: 1331-1337; Cat. No. AB19551, AbCam Ltd., Cambridge, UK) is incubated at a final concentration of 100 ⁇ g/ml in HEPES buffer (pH 7.4) with GNA as prepared above at a final concentration of 1 mg/ml for twenty minutes at ambient temperature. The mixture is then washed four times with excess sample buffer, then stored at 4° C. until use. A fraction is subjected to SERS to obtain baseline values.
- Fluid samples from individuals with diagnosed ovarian cancer are incubated with SQD in the presence of a conjugating agent and linker molecule for 20 minutes at ambient temperature.
- the mixture is washed four times and resuspended in HEPES buffer (pH 7.4) to produce SQD-Ag conjugate.
- a fraction is subjected to SQD luminescence to obtain baseline values.
- the SQD-Ag conjugate is added to OC125-GNA mixture in HEPES incubation medium (pH 7.4) at ambient temperature for 8 hours.
- Control samples are from individuals without diagnosed disease or disorders.
- the samples are then washed four times with incubation medium, resuspended in sample buffer, and then divided into two fractions. One fraction is subjected to SQD luminescence. The other fraction is subjected to SERS. Baseline values obtained earlier are then compared with the values obtained under experimental conditions.
- Antigen substantially purified using polyacrylamide gel electrophoresis (PAGE; see, for example, Harrington (1990) Methods Enzymol. 182: 488-495) or other purification techniques is used to immunize rabbits and to produce antibodies using standard protocols.
- the antigen amino acid sequence is analyzed using DNASTAR software (DNASTAR Inc., Madison Wis.) to determine regions of high immunogenicity, and a corresponding oligopeptide is synthesized and used to raise antibodies by means known to those of skill in the art. Methods for selection of appropriate epitopes, such as those near the C-terminus or in hydrophilic regions are well described in the art. (See, for example, Ausubel et al. supra, chapter 11.)
- the oligopeptides are 15 residues in length, and are synthesized using an Applied Biosystems Peptide Synthesizer Model 431 A using Fmoc-chemistry and coupled to KLH (Sigma-Aldrich, St. Louis, Mo.) by reaction with N-maleimidobenzoyl-N-hydroxysuccinimide ester to increase immunogenicity.
- Applied Biosystems Peptide Synthesizer Model 431 A using Fmoc-chemistry and coupled to KLH (Sigma-Aldrich, St. Louis, Mo.) by reaction with N-maleimidobenzoyl-N-hydroxysuccinimide ester to increase immunogenicity.
- KLH Sigma-Aldrich, St. Louis, Mo.
- Rabbits are immunized with the oligopeptide-KLH complex in complete Freund's adjuvant.
- Resulting antisera are tested for antipeptide activity, for example, by binding the peptide to plastic, blocking with 1% BSA, reacting with rabbit antisera, washing, and reacting with radio-iodinated goat anti-rabbit IgG.
- a non-peptide antigen is used and is conjugated to KLH.
- Naturally occurring or recombinant antigen is substantially purified by immunoaffinity chromatography using antibodies specific for the antigen.
- An immunoaffinity column is constructed by covalently coupling anti-antigen antibody to an activated chromatographic resin, such as CNBr-activated Sepharose (Pharmacia & Upjohn, Kalamazoo Mich.). After the coupling, the resin is blocked and washed according to the manufacturer's instructions.
- Media containing antigen are passed over the immunoaffinity column, and the column is washed under conditions that allow the preferential absorbance of antigen (for example, high ionic strength buffers in the presence of detergent).
- the column is eluted under conditions that disrupt antibody/antigen binding (for example, a buffer of pH 2 to pH 3, or a high concentration of a chaotrope, such as urea or thiocyanate ion), and antigen is collected.
- Antigen, or biologically active fragments thereof, are labeled with [ 125 I] Bolton-Hunter reagent. (See, for example, Bolton and Hunter (1973) Biochem. J. 133: 529-539.)
- Bolton-Hunter reagent See, for example, Bolton and Hunter (1973) Biochem. J. 133: 529-539.
- Candidate molecules previously arrayed in the wells of a multi-well plate are incubated with the labeled antigen, washed, and any wells with labeled antigen complex are assayed. Data obtained using different concentrations of antigen are used to calculate values for the number, affinity, and association of antigen with the candidate molecules.
- Fiber surface enhanced Raman scattering (SERS) sensors show great potential for in vivo and in vitro detection, however, current probes based on end polished fibers suffer from small signal due to their small active region.
- SERS Fiber surface enhanced Raman scattering
- End tip fiber optic SERS probes have been shown to produce excellent results with high stability and portability, where a fiber with a flat, angled, or tapered tip was modified with silver island films, roughened silver films, or silver film over nanospheres to produce the SERS substrate (see Stokes et al. (2004) Applied Spectroscopy 58: 292; Stokes and Vo-Dinh (2000) Sensors and Actuators B-Chemical 69: 28; Mullen and Carron (1991) Anal. Chem. 63: 2196; Gessner et al. (2004) Analyst 129: 1193; Viets and Hill (1998) Sensors and Actuators B-Chemical 51: 92; Viets and Hill (2000) J. Raman Spectrosc.
- DSF D-shaped fiber
- the SERS fibers were created by mixing 20 ⁇ l of silver nanoparticles with 5 ⁇ l of 0.1 mM rhodamine 6G (R6G) and drying a drop of this solution on the fiber under ambient conditions. SERS experiments were then performed on these devices in two configurations.
- a 780 nm diode laser is either coupled into the fiber ( FIG. 19 ) or into a Renishaw micro-Raman spectrometer with a 20 ⁇ objective. In both configurations the micro-Raman spectrometer collects the scattered light from the DSF. Samples were nominally integrated for 40 seconds for one scan with a laser intensity of ⁇ 3 mW.
- FIG. 20 shows the simulation result of a Corning 28e fiber covered with a silver nanoparticle aggregate layer. The plot in FIG. 20 shows the intensity distribution across the polished surface (top view illustrated).
- a large absorption constant was chosen because of the resonant absorption of the Ag nanoparticle aggregates at 780 nm wavelength.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Nanotechnology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
The invention is drawn to novel gold nanoparticles that are used in a dual optical method for sensitive and selective detection of antigens. The gold nanoparticle aggregates are synthesized from gold hydrochloride and sulfur salts in an aqueous solution. The aggregates can be selectively sized using a spectral notch filter that results in an improved product with versatile uses. The gold nanoparticles can also be used in improved optical communications devices.
Description
- The present application claims priority to U.S. Provisional Patent Application Ser. No. 60/667,151 entitled “Novel Gold Nanoparticle Aggregates and Their Applications”, filed Mar. 30, 2005, and U.S. Provisional Patent Application Ser. No. 60/711,808 entitled “Novel Gold Nanoparticle Aggregates and Their Applications”, filed Aug. 26, 2005, which are herein incorporated by reference in their entirety for all purposes.
- The present invention relates to particles comprising a metallic core and sulfur species on their surface with useful properties. The invention further relates to methods of using the particles for detecting chemical and biological analytes, and in use in optical communications.
- During the 1980s Raman Scattering in fibers was demonstrated by Lin, Stolen, and other co-workers of AT&T Bell Laboratories in Holmdel, N.J. using Raman lasers operating between 0.3 to 2.0 μm. In the early years of the Raman fiber before extensive work had begun, no one perceived that a Raman fiber could be pumped by a practical semiconductor laser-based source or that an efficient CW-pumped Raman Fiber Laser was possible. However, with the development of Cladding-pumped Fiber Lasers and Fiber Bragg Gratings, diode-laser-based CW Raman Fiber Lasers have been made efficient, emitting at various wavelengths throughout the infrared spectrum a reality. (See van Gisbergen et al. (1996) Chem. Phys. Lett. 259: 599-604.)
- Raman spectroscopy is a powerful optical technique for detecting and analyzing molecules. Its principle is based on detecting light scattered off a molecule that is shifted in energy with respect to the incident light. The shift, called Raman shift, is characteristic of individual molecules, reflecting their vibrational frequencies that are like fingerprints of molecules. As a result, the key advantage of Raman spectroscopy is its molecular specificity while its main limitation is the small signal due to low quantum yield of Raman scattering. One way to enhance the Raman signal is to tune the excitation wavelength to be on resonance with an electronic transition, so called resonance Raman scattering. This can usually produce an enhancement on the order of 102-103.
- Another technique to enhance Raman scattering is surface enhancement by roughened metal surfaces, notably silver and gold, that provides an enhancement factor on the order of 106-108. This is termed surface enhanced Raman spectroscopy (SERS). Similar or somewhat larger enhancement factors (˜108-1010) have been observed for metal, mostly silver or gold, nanoparticles.
- In the last few years, it has been shown that an even larger enhancement (˜1010-1015) is possible for aggregates of metal nanoparticles (MNPs), silver and gold. The largest enhancement factor of 1014-1015 has been reported for rhodamine 6G (R6G) on single silver nanoparticle aggregates. This huge enhancement is thought to be mainly due to significant enhancement of the local electromagnetic field of the nanoparticle aggregate that strongly absorbs the incident excitation light for the Raman scattering process. With such large enhancement, many important molecules that are difficult to detect with Raman normally can now be easily detected. This opens many interesting and new opportunities for detecting and analyzing molecules using SERS with extremely high sensitivity and molecular specificity.
- SERS can also be developed into a molecular imaging technique for biomedical and other applications. Existing Raman imaging equipment should be usable for SERS imaging. SERS will provide a much-enhanced signal and thereby significantly shortened data acquisition time, making the technique practically useful for medical or other commercial and industrial applications including chip inspection or chemical monitoring. SERS is also useful for detecting other cancer biomarkers that can interact or bind to the MNP surface. For example, Sutphen et al. have recently shown that lysophospholipids (LPL) are potential biomarkers of ovarian cancer (Sutphen et al. (2004) Cancer Epidemiol. Biomarker Prev. 13: 1185-1191).
- For many practical applications, for example SERS and optical filters, it is highly desirable to narrow the distribution of size/shape of nanoparticle aggregates. For SERS in particular, the incident light has to be on resonance with the substrate absorption. Only those nanoparticle aggregates that have resonance absorption of the incident light are expected to be SERS active. It is thus extremely beneficial to have a narrow size/shape distribution and thereby narrow optical absorption.
- Fluorescent nanoparticles (quantum dots (QDs) such as semiconductor quantum dots, SQDs) have been used recently as fluorescent biological markers and have been found to be extremely effective. They offer advantages including higher stability, stronger fluorescence, tunability of color, and possibility of optical encoding based on different sized or colored SQDs.
- A method of synthesis for gold nanoparticle aggregates (GNAs) has been described in the prior art (see Norman et al. (2002) J. Phys. Chem. B, 106: 7005-7012). Norman used Na2S and HAuCl4 (chloroauric acid). Norman suggested that the product of the reaction is elemental sulfur, elemental gold, free protons, and free chlorine ions. This contrasts with the alternative dogma that the aggregates comprise an Au2S core enveloped by an Au shell. Therefore Norman concluded that the reaction produces aggregates of gold nanoparticles having amorphous sulfur on their surface.
- Metal nanoparticles have been recognized for their unique optical properties that could be exploited in optoelectronic devices. Nanoparticle systems composed of gold, for example, have distinct optical properties that make them amenable to study by Raman scattering. The Raman spectrum of the adsorbed species is significantly enhanced by 10 to 15 orders of magnitude when the metal nanoparticles have aggregated, leading to enhanced electromagnetic field effects near the surface that increases the Raman scattering intensity. The greater sensitivity found in the surface enhanced Raman spectroscopy (SERS) of metal nanoparticle aggregates facilitates the detection and analysis of a whole host of molecules that were previously difficult to study.
- Wang et al. disclose a method of using SQDs (dye-conjugated CdTe nanoparticles, CT-NPs) to detect interactive binding between Ag-CT-NPs and Ab-CT-NPs (Wang et al. (2002) NanoLett. 2: 817-822). The interactions were determined by differential quenching or enhancement fluorescence activity of two different sized SQDs (red or green) measured during the analysis.
- The chemical methods used historically for the production of gold nanoparticle aggregates (GNAs) results in a wide distribution of aggregate size. This distribution leads to a broadened absorption spectrum. Accordingly, researchers have attempted to narrow the lineshape of the spectral peak due to the aggregates by homogenizing the size of the GNAs after they have been produced. By eliminating certain ranges of aggregate size, absorption spectrum peaks should narrow appreciably and concomitantly increase in intensity, resulting in more sensitive detection. Previous attempts to select for a narrow size range of aggregates have employed mechanical techniques such as passing a solution of aggregates through a filter. For example, Emory & Nie have employed size-selective fractionation using membrane filters to select for optically active silver nanoparticles (Emory and Nie, (1997) J. Phys. Chem. B, 102: 493-497).
- The use of SERS for analyte detection of biomolecules has been previously studied. U.S. Pat. No. 6,699,724 to West et al. describes a chemical sensing device and method (nanoshell-modified ELISA technique) based on the enzyme-linked immunoadsorbant assay (ELISA). The chemical sensing device can comprise a core comprising gold sulfide and a surface capable of inducing surface enhanced Raman scattering (SERS). In much of the patent disclosure, the nanoparticle is disclosed as having a silica core and a gold shell. The patent discloses that an enhancement of 600,000-fold (6×105) in the Raman signal using conjugated mercaptoaniline was observed.
- In the nanoshel-modified ELISA technique, antibodies are directly bound to the metal nanoshells. Raman spectra are taken of the antibody-nanoshell conjugates before and after the addition of a sample containing a possible antigen, and binding of antigen to antibody is expected to cause a detectable shift in the spectra.
- The conjugation of quantum dots to antibodies used for ultrasensitive nonisotopic detection for use in biological assays has also been studied. U.S. Pat. No. 6,468,808 B1 to Nie et al. disclosed an antibody is conjugated to a water-soluble quantum dot. The binding of the quantum dot-antibody conjugate to a targeted protein will result in agglutination, which can be detected using an epi-fluorescence microscope. In addition, Nie et al. described a system in which a quantum dot is attached to one end of an oligonucleotide and a quenching moiety is attached to the other. The preferred quenching moiety in the Nie patent is a nonfluorescent organic chromophore such as 4-[4′-dimethylaminophenylazo]benzoic acid (DABCYL).
- Raman amplifiers are also expected to be used globally as a key device in next-generation optical communications, for example, in wavelength-division-multiplexing (WDM) transmission systems. Raman scattering occurs when an atom absorbs a photon and another photon of a different energy is released. The energy difference excites the atom and causes it to release a photon with low energy; therefore, more light energy is transferred to the photons in the light path.
-
FIG. 6 shown how the Raman amplifier operates. The Raman amplification process begins as a seed beam (incoming light) passes through the optical fiber. While it is traveling, a stronger pump beam is released from another light source and is deflected using a refractive material, such as a mirror. The pump beam and seed beam then come in contact with each other and the seed beam depletes the energy of the pump beam; therefore the intensity of the light increases and the signal is amplified. Now the signal is capable of traveling long distances, for example, more than 70 km, without losing a signal. (See, for example, U.S. Pat. No. 6,292,288; Vinson and Webb (2001) Light Amplification: The Future Of Optical Communications, Optical Engineering UCSC, Summer Ventures of Science and Math, 2001, 7 pp.) - There is therefore a need in the art for use in the biomedical analytical industries and the optical communications industries to provide more sensitive compositions and devices that are inexpensive to manufacture and easy to use.
- The present invention provides a chemical sensor comprising a plurality of particles, each particle comprising: a core, a shell having at least one surface and having contact with the core and wherein the shell comprises a sulfur-oxygen molecular species, and wherein the particle has been selectively sized using a notch filter and electromagnetic radiation, the electromagnetic radiation having a spectral wavelength of between about 350 nm and about 1075 nm. In one embodiment the particle has a size in the range of about 60 and 200 nm. In another embodiment the particle has a size selected from the range of between about 60 and 150 nm, between about 60 and 100 nm, between about 60 and 80 nm, between about 80 and 200 nm, between about 80 and 150 nm, between about 80 and 100 nm, between about 100 and 200 nm, between about 100 and 150 nm, and between about 150 and 200 nm.
- In a preferred embodiment the core comprises a metal selected from the group consisting of gold, silver, platinum, copper, aluminum, palladium, cadmium, iridium, and rhodium. In a more preferred embodiment the core comprises gold.
- In another preferred embodiment the electromagnetic radiation has a spectral wavelength of between about 350 nm and about 650 nm and between about 950 nm and about 1075 nm. In yet a more preferred embodiment the electromagnetic radiation has a spectral wavelength of between about 350 nm and about 775 nm and between about 875 nm and about 1075 nm.
- In another embodiment, the chemical sensor comprises a shell that further comprises a linker molecule, the linker molecule selected from the group consisting of a thiol group, a sulfide group, a phosphate group, a sulfate group, a cyano group, a piperidine group, an Fmoc group, and a Boc group.
- In yet a further embodiment, the chemical sensor comprises a support. In a preferred embodiment, the support comprises a medium that is permeable to an analyte of interest.
- In another preferred embodiment, the chemical sensor has a surface wherein the surface can induce surface enhanced Raman scattering (SERS).
- In still another preferred embodiment, the chemical sensor further comprises at least one detecting molecule, wherein the detecting molecule is bound to the surface. In a more preferred embodiment the detecting molecule is selected from the group consisting of proteins, peptides, antibodies, antigens, nucleic acids, peptide nucleic acids, sugars, lipids, glycophosphoinositols, and lipopolysaccharides.
- In a yet more preferred embodiment the detecting molecule is an antibody. In another preferred embodiment, the detecting molecule is an antigen.
- In another embodiment, the invention provides a chemical sensor further comprising at least one semiconductor quantum dot. In a preferred embodiment the semiconductor quantum dot further comprises a linker molecule, the linker molecule selected from the group consisting of a thiol group, a sulfide group, a phosphate group, a sulfate group, a cyano group, a piperidine group, an Fmoc group, and a Boc group.
- In a still further embodiment, the invention provides a chemical sensor comprising at least one semiconductor quantum dot wherein the semiconductor quantum dot further comprises a detecting molecule, wherein the detecting molecule is bound to the semiconductor quantum dot. In a more preferred embodiment, the detecting molecule is selected from the group consisting of proteins, peptides, antibodies, antigens, nucleic acids, peptide nucleic acids, sugars, lipids, glycophosphoinositols, and lipopolysaccharides.
- In a more preferred embodiment, the detecting molecule is an antibody. In the alternative, a more preferred embodiment comprises a chemical sensing device wherein the detecting molecule is an antigen.
- Another embodiment of the invention provides a method for detecting an analyte in a sample using a chemical sensor, the method comprising the steps of: i) providing a sample; ii) providing a semiconductor quantum dot comprising a linker molecule (LM-SQD); iii) conjugating the analyte in the sample with the LM-SQD thereby producing an analyte-LM-SQD conjugate; iv) providing a chemical sensor comprising a plurality of particles, each particle comprising: a core, a shell having at least one surface and having contact with the core and wherein the shell comprises a sulfur-oxygen molecular species, and wherein the particle has been selectively sized using a notch filter and electromagnetic radiation, the electromagnetic radiation having a spectral wavelength of between about 350 nm and about 1075 nm, the shell surface further comprising a detecting molecule; v) incubating the analyte-LM-SQD conjugate with the chemical sensor for a predetermined time period; and vi) measuring the extent of binding between the analyte-LM-SQD conjugate and the chemical sensor; thereby detecting the analyte in the sample.
- In a preferred embodiment the invention provides a method for detecting an analyte that is an ovarian cancer marker antibody. In one embodiment of the invention the detecting molecule in the chemical sensing device is an antigen that binds to an ovarian cancer marker antibody with an affinity (Ka) of at least 106 l/mole. In a more preferred embodiment the Ka is at least 108 l/mole. In another preferred embodiment the analyte is a phospholipid. In a most preferred embodiment the phospholipid is lysophosphatidic acid (LPA).
- In another embodiment, the invention provides an optical fiber, the fiber being shaped and adapted to provide a substrate surface for the chemical sensor. The fiber has a proximal end and a distal end. In one embodiment, the fiber is shaped having a D-shape cross-section; in another embodiment the distal end of the fiber is tapered to provide a large substrate surface. In a more preferred embodiment the fiber has at least two substrate surfaces.
- In a yet additional embodiment, the invention provides an optical communications device comprising a fiber, a plurality of particles, each particle comprising: a core, a shell having at least one surface and having contact with the core and wherein the shell comprises a sulfur-oxygen molecular species, and wherein the particle has been selectively sized using a notch filter and electromagnetic radiation, the electromagnetic radiation having a spectral wavelength of between about 350 nm and about 1075 nm.
- In a more preferred embodiment the optical communications device comprises a fiber, wherein the fiber is selected from the group consisting of ceramics, glasses, polymers, and metal-polymer composites. In one preferred embodiment the fiber cross-section is D-shaped. In another preferred embodiment the chemical sensor is disposed upon a surface of the fiber.
- The invention also provides a method for synthesizing a chemical sensor comprising gold nanoparticle aggregates, the method comprising the steps of (i) providing one volume (1V) of a solution of 0.1 M HAuCl4; (ii) diluting the solution of HAuCl4 with Milli-Q water to a final concentration of between 4×10−4-6×10−4 M HAuCl4; (iii) combining the diluted solution of HAuCl4 with a 0.1 M solution of Na2S to a final concentration of HAuCl4 of between 4×10−5-6×10−5M HAuCl4; (iv) incubating the combined solution for about between 60-120 minutes; and (v) measuring the extended plasmon band of the combined solution until the near-infra-red (NIR) absorption is at a wavelength longer than 600 nm, thereby synthesizing a chemical sensing particle comprising gold nanoparticle aggregates. In one alternative, the 0.1 M solution of Na2S of step (iii) is substituted with an equal volume of 0.1M Na2S2O3.
- The invention also provides a method for coating gold nanoparticle aggregates onto a substrate, the method comprising the steps of (i) providing the gold nanoparticle aggregates as disclosed above; (ii) submerging the gold nanoparticle aggregates in a 5 mM aqueous solution of a tethering molecule, the tethering molecule selected from the group consisting of trimethoxy[3-(methylamino)propyl]silane (APS) and (3-mercaptopropyl)trimethoxy silane (MPS), a compound having a silane terminus and a thiol or amine terminus, and the like; (iii) incubating the gold nanoparticle aggregates with the tethering molecule to allow the gold nanoparticle aggregates to adsorb the tethering molecules; (iv) providing a substrate, wherein the substrate is selected from the group consisting of silicon dioxide, silicon, and the like; (v) sonicating the substrate in contact with a 2% solution of surfactant, the surfactant selected from the group consisting of HELLMANEX, ALCONOX, a small molecule alkaline surfactant, and the like; (vi) sonicating the substrate with 18 mΩ water; (vii) drying the substrate under nitrogen gas; (viii) depositing a volume of the adsorbed gold nanoparticle aggregates and tethering molecules solution onto the surface of the substrate; (ix) incubating the substrate with the solution for five seconds; (x) blowing the substrate dry with nitrogen gas; wherein the incubation time for step (iii) is selected from the group consisting of 30 minutes, 60 minutes, 90 minutes, and 120 minutes, the method resulting in gold nanoparticle aggregates coated onto a substrate.
- The invention also provides a method for creating a chemical sensor with improved sensitivity, the method comprising the steps of: (i) providing the chemical sensing particle comprising gold nanoparticle aggregates as disclosed above; (ii) illuminating the gold nanoparticle aggregates with an amplified femtosecond beam at a flux of approximately 0.1 mJ/cm2 for 1 hour; (iii) illuminating the gold nanoparticle aggregates using a tunable picosecond laser, thereby creating a chemical sensor with improved sensitivity.
-
FIG. 1 shows representative electronic absorption spectra of gold nanoparticle aggregates in water during the growth and aggregation process. -
FIG. 2 shows results from a persistent spectral hole burning experiment using ˜800 nm laser light at 200 μJ/pulse. -
FIG. 3 shows an illustration of how narrowing aggregate size/shape distribution using light is achieved. -
FIG. 4 shows a schematic illustration of how photoluminescence (PL) of an SQD-Ab conjugate is quenched by an MNP-Ag conjugate. -
FIG. 5 shows the results of two SDQ quenching experiments: two SERS spectra of an SQD-Ab (polyclonal donkey anti-goat Ab) conjugate having been quenched by an MNP-Ag conjugate (pink and dark red) and one control SERS spectrum of an SQD without a conjugated Ab (blue). -
FIG. 6 is an illustration of how a Raman amplifier functions to intensify a photon beam. -
FIG. 7A is an illustration of an exemplary optical fiber having a substrate surface parallel to the axis of the fiber. -
FIG. 8A illustrates an alternative exemplary optical fiber having a single distal substrate surface at an angle to the axis of the fiber. -
FIG. 9 illustrates the path of a photon within the fiber and shown interacting with a nanoparticle aggregate conjugated compound on the substrate surface of the fiber and the resulting SERS photon. -
FIG. 10A illustrates another alternative exemplary optical fiber having two distal substrate surfaces. -
FIG. 11 illustrates the path of photons within the fiber and shown interacting with nanoparticle aggregate conjugated compound on the substrate surfaces of the fiber and the resulting SERS photons. -
FIG. 12 illustrates the distal end of a fiber positioned in proximity to the ends of two additional fibers that transmit the SERS photon to a detector. -
FIG. 13 illustrates the angle of the distal substrate surface to the longitudinal plane of the fiber. -
FIG. 14 shows a representative UV-visible absorption spectrum of silver nanoparticles. The absorption towards the 780 nm region is believed to be sufficient for SERS to occur. -
FIG. 15 shows a Raman spectrum of bulk lysophosphatidic acid crystals (780 nm excitation, 3 mW power) for 16:0 LPA. -
FIG. 16 shows a Raman spectrum of bulk lysophosphatidic acid crystals (780 nm excitation, 3 mW power) for 18:0 LPA. -
FIG. 17 shows SERS spectra of one hundred samples of 10−6 M solutions of 16:0 LPA and 18:0 LPA dried on silver nanoparticles (780 nm excitation, 3 mW power). -
FIG. 18 shows the SERS region between 1050 cm−1-1150 cm−1 for 100×10−6 M solutions of 16:0 LPA and 18:0 LPA to show the distinguishable mode at 1097 cm−1 and 1101 cm−1 (780 nm excitation, 3 mW power). -
FIG. 19 illustrates a schematic of the Raman probe with a D-shaped (or side-polished) fiber coated with SERS substrate on the flat surface. Only the end segment of the fiber (about 1 cm) that is polished is shown. The rest of the unpolished fiber is about 0.5 m. -
FIG. 20 illustrates the intensity distribution as light propagates through the D-shaped fiber covered with a silver film. Area shown is a cross-section parallel to the polished surface and through the center of the fiber core (top view). Inset: contour plot of the intensity distribution in a cross-section perpendicular to the fiber axis (end view). The semi-circle area is the fiber core with the cladding outside the half-circle. The thick black line above the semi-circle represents a 0.1 mm metal particle thin film and above the film (the top blue rectangle) is the air. -
FIG. 21 illustrates a representative SERS spectra of rhodamine 6G on silver nanoparticles dried onto a D-shaped fiber collected with excitation laser incident to fiber surface (A) and coupled into the fiber (B). - The embodiments disclosed in this document are illustrative and exemplary and are not meant to limit the invention. Other embodiments can be utilized and structural changes can be made without departing from the scope of the claims of the present invention.
- As used herein and in the appended claims, the singular forms “a,” “an,” and “the” include plural reference unless the context clearly dictates otherwise. Thus, for example, a reference to “a particle” includes a plurality of such particles, and a reference to “a surface” is a reference to one or more surfaces and equivalents thereof, and so forth.
- We have recently discovered that the reaction of chloroauric acid (HAuCl4) with sodium sulfide (Na2S) results in generation of novel gold nanoparticle aggregates (GNAs). These GNAs have unique optical and surface properties that are useful for applications, for example, surface enhanced Raman scattering (SERS), as a chemical sensor. SERS is a known and powerful technique for detecting molecules with high sensitivity and specificity. First, the GNAs we discovered are in aqueous solution and thereby naturally compatible with biological samples in water. Second, the GNAs have strong near IR absorption (650-1200 nm) that is ideal for biological applications due to better tissue penetration in this spectral region. Third, these GNAs have unique surface properties due to sulfur species on their surface that not only causes the aggregation in the first place but also provides a strong driving force for binding with chemical and biological molecules with high affinity for sulfur. Some of the potential applications will be outlined separately in the following sections.
- The surface properties are undoubtedly due to the component sulfur and oxygen atoms (such as, but not limited to molecules of negatively charged SxOy, wherein x=1 or 2 and y=1, 2, 3, or 4).
- The particles can have a size range of about between 60 and 200 nm.
-
FIG. 1 shows some representative electronic absorption spectra of the GNAs in water during the growth process. The spectrometer used limits the measurements to about 850 nm in the near IR. The strong near IR band is clearly visible in the spectra. - We have also discovered based on transient absorption and hole burning studies that the broad near IR absorption of the GNAs is inhomogeneously broadened due to a distribution of sizes and/or shapes (see
FIG. 2 ). Since the hole burned is permanent, this immediately led us to propose the idea of using light (such as, but not limited to, high power lasers) to narrow the distributions of size/shape distribution. The idea is outlined inFIG. 3 using a combination of “white light” and notch filters to convert GNAs absorbing outside the notch filter covered region into GNAs that absorb only in the notch filter covered region. A significant increase in the number of GNAs in the notch filter covered region through this process is achieved. - This is useful since for many practical applications, for example, SERS and optical filters, it is highly desirable to narrow the distribution of size/shape of nanoparticle aggregates. For SERS in particular, the incident light has to be on resonance with the substrate absorption. Only those GNAs that have resonance absorption of the incident light are expected to be SERS active. It is thus extremely beneficial to have a narrow size/shape distribution and thereby narrow optical absorption.
- A white light source with a particular wavelength blocked by an optical notch filter is used to irradiate a sample of GNA having a broad distribution of aggregate sizes and shapes. All the aggregates can be either destroyed and/or converted into the aggregates that absorb at the blocked wavelength. This can significantly reduce the size and shape distribution of the aggregates. Only aggregates that absorb (on resonance) with the blocked wavelength will remain and such aggregate samples are stable. This principle can work for many other metal nanoparticle aggregates such as silver, Pt, and Pd, etc. The size/shape-narrowed aggregates are useful for many applications such as SERS or can be used as an optical filter with a fairly narrow bandwidth. The aggregates can further be patterned onto a solid substrate and used for any application that can benefit from narrow distributed metal nanoparticle aggregates.
-
FIG. 2 shows the results of a persistent spectral hole burning experiment using ˜800 nm laser light at 200 μJ/pulse. Trace a) is prior to laser irradiation. Trace b) is after 2.5 hours of hole burning. A hole is clearly seen in trace b) as well as a growth and shift of the maximum absorbance to bluer wavelengths. The SERS enhancement has been observed as being at about one-billion-fold (109) that is approximately three to four orders of magnitude greater than that disclosed in the prior art. Such an increase in enhancement therefore results in a reagent with greater sensitivity than other systems. - One potential application using this optical narrowing effect is proposed here. By exposing the aggregate solution to varying wavelengths of light it may be possible to burn away all but a narrow absorption band anywhere from 650 nm to 950 nm. This is shown schematically in the left portion of
FIG. 3 . As shown in the right portion ofFIG. 3 , a composition comprising particles having a narrow range of absorbance is created. By suspending these particles in glass, a low cost notch filter is produced. Current notch filters are highly expensive and difficult to produce. With this technology it is possible to produce good quality notch filters at very low costs. While these filters might not be as high quality as current high cost filters, there is a large market for low cost, low-end filters where high precision is not required. The market mainly comprises fiber-optical communications devices that are used to transmit information using photons instead of electrons. The devices comprise light amplifiers that retain the intensity of light as it travels through fiber optic networks. Light amplifiers are used to increase the intensity of weak light signals as they travel through long distances of fiber optic networks. The most commonly used form of light amplification is the Raman amplifier because it has proven to be the most efficient. This technique increases the frequency of transmitted light signals within a fiber optic network to prevent a loss of transferred data. This market has not currently been tapped in notch filters. - Raman spectroscopy is a powerful optical technique for detecting and analyzing molecules. Its principle is based on detecting light scattered off a molecule that is shifted in energy with respect to the incident light. The shift, called Raman shift, is characteristic of individual molecules, reflecting their vibrational frequencies that are like figure prints of molecules. As a result, the key advantage of Raman spectroscopy is its molecular specificity while its main limitation is the small signal due to low quantum yield of Raman scattering. One way to enhance the Raman signal is to tune the excitation wavelength to be on resonance with an electronic transition, so called resonance Raman scattering. This can usually produce an enhancement on the order of 102-103. Another technique to enhance Raman scattering is surface enhancement by roughened metal surfaces, notably silver and gold, that provides an enhancement factor on the order of 106-108. Similar or somewhat larger enhancement factors (˜108-1010) have been observed for metal, mostly silver, nanoparticles.
- In the last few years, it has been shown that an even larger enhancement (˜1010-1015) is possible for aggregates of metal nanoparticles, for example, comprising silver and/or gold. The largest enhancement factor of 1014-1015 has been reported for rhodamine 6G (R6G) on single silver nanoparticle aggregates. This huge enhancement is thought to be mainly due to significant enhancement of the local electromagnetic fields of the nanoparticle aggregates that absorb strongly the incident excitation light for the Raman scattering process. With such large enhancement, many important molecules that are difficult to detect with Raman normally can now be easily detected. This provides many interesting and new opportunities for detecting and analyzing molecules using SERS with extremely high sensitivity and molecular specificity.
- Of emphasis are the unique surface properties of the aggregates. It is these surface properties that make the gold nanoparticles aggregate in the first place and make the aggregates useful for SERS as a substrate with desirable properties.
- Given the particular surface and optical features of the GNAs we have found, they can be suitable for SERS detection and analysis of a large number of molecules, including, but not limited to, proteins, DNA, explosives, chemical and biological warfare agents, toxins, and even virus and biological cells. We have demonstrated that the GNAs are SERS active for amino acids and DNA bases as well as antibodies for cancer detection. As discussed in
Section 2 above, the possibility of narrowing the optical absorption of the GNAs for SERS is an important added advantage. - SERS can also be developed into a molecular imaging technique for biomedical and other applications. Exciting Raman imaging equipment may be usable for SERS imaging. SERS can provide an enhanced signal and thereby significantly shortened data acquisition time, making the technique practically useful for medical or other commercial and industrial applications including, but not limited to, chip inspection or chemical monitoring.
- 4. Antigen/Antibody Detection with Metal and Semiconducting Nanoparticles
- Fluorescent nanoparticles (semiconductor quantum dots, SQDs) have been used recently as fluorescent biological markers and have been found to be extremely effective. They offer advantages including higher stability, stronger fluorescence, tunability of color, and possibility of optical encoding based on different sized or colored SQDs.
- GNAs of the invention can be used to detect an analyte. Such an analyte can be, for example, but not limited to, an antigen, an antibody, a biochemical metabolite, an organic compound, a compound or element having biological activity, or the like.
- For example, the GNAs of the invention can be used in a novel dual optical scheme for sensitive and selective detection of antigens and is illustrated in
FIG. 4 . The technique is based on detection of photoluminescence from SQDs with antibody (Ab) attached and SERS (surface enhanced Raman scattering) spectra of antigen (Ag) attached to the GNAs that comprise metal nanoparticles (MNP). SERS spectrum is a measure of the Raman spectrum of the Ag that can be significantly enhanced by a metal nanoparticle. The Raman spectrum, similar to an infra-red (IR) spectrum, is characteristic of specific molecules due to the unique set of vibrational frequencies of each molecule. Before the Ag and Ab interact or bind to one another, we expect strong photoluminescence (PL) from the SQD and a well-defined SERS spectrum. Upon binding of Ab with the complementary Ag, two important consequences can occur. First, the PL from the SQD will be significantly, if not completely, quenched by the GNA-Ab complex. Second, the SERS spectrum of the Ag will change with small but noticeable frequency shift and/or relative spectral intensity changes due to Ag-Ab interaction. It is well known that PL from fluorophores can be significantly quenched when brought near a metal surface (bulk or nanostructured). The distance at which quenching occurs is a known parameter and is of the order of between about 1-2 nm for effective quenching. The distance will be dependent on the sizes of the SQD, GNA, Ag, and Ab, the length of a linker molecule (LM) between the SQD and the Ag (or alternatively, between the SQD and the Ab, between the GNA and Ab, or between the GNA and Ag), as well as on their relative binding configuration. We can estimate at this point that a certain favorable configuration and size will allow quenching. This is supported by a recent report from Wang et al. that PL quenching of a small, green-emitting QD with antibody attached by large, red-emitting QD with antigen attached occurs when the Ag and Ab interact (Wang et al. (2002) NanoLett., 2: 817-822). This experiment demonstrates that the distance can be close enough for effective PL quenching due to resonance energy transfer from the large QD to the smaller QD. - As for the SERS aspect, we have very recently demonstrated that we can detect the SERS spectrum of a polyclonal Ab attached to gold nanoparticles through electrostatic interaction.
FIG. 5 shows two representative SERS spectra where the reproducible peaks can be attributed to the Ab. To our best knowledge, this is the first demonstration of SERS detection of Ab. Since Raman or SERS spectrum is extremely sensitive to the structure, configuration and environment of a molecule, we anticipate that the SERS spectrum of an Ab can change upon interaction with its Ag. - The proposed scheme offers a novel technique for detecting antigen with high sensitivity (offered by both PL and SERS) and specificity (offered by both SERS and Ag-Ab interaction). In a typical experiment, we choose a laser wavelength that is on resonance with absorption of the QD (usually in the near UV and visible region) for measuring PL from the SQD with Ab attached, with and without binding to Ag attached to GNA. We then choose a laser wavelength that is off-resonance for the SQD absorption and produces no PL for SERS measurement (usually near IR) of the Ag attached to GNA, with and without binding with Ab attached to SQD. Comparing the two situations with and without Ag-Ab binding, we can see PL quenching of the SQD and SERS spectral change upon binding. Since the PL quenching of the SQD by a GNA is expected to be much more effective than a large SQD, the PL can be completely quenched in the situation with Ag-Ab binding. This is thus a zero-background experiment and can be much more sensitive than conventional PL detection that is typically not zero-background. For SERS, since the enhancement can be as high as 109, it is almost as sensitive as fluorescence but has the extremely important advantage of direct molecular specificity between the Ag and the Ab.
- In another example, the Ag can be replaced by a second Ab, the second Ab being specific for binding the first Ab. The second antibody can be from the same animal species as the first Ab, or can be from another animal species. Such first and second Abs are well known to those in the art and can be raised in and isolated from an animal such as, but not limited to, a rabbit, a human, a mouse, a rat, a monkey, an ape, a goat, a sheep, a cow, a pig, a donkey, a horse, a guinea pig, a whale, a wombat, a platypus, or the like.
- SERS is also useful for detecting other cancer biomarkers that can interact or bind to the GNA surface. For example, Sutphen et al. have recently shown that lysophospholipids (LPL) are potential biomarkers of ovarian cancer (Sutphen et al. (2004) Cancer Epidemiol Biomarker Prev., 13: 1185-1191). Based on the molecular structure of LPL molecules, a favorable interaction between LPL molecules with GNA through electrostatic interaction can occur at the appropriate pH. In the case of the SERS experiment using a polyclonal Ab shown in
FIG. 5 , the strongest interaction with GNA occurs at the isoelectrostatic pH, i.e. pH at which the GNA has equal number of positive and negative charges. The pH is varied to adjust the charge on the GNA to determine the optimal pH or charge for strong interaction with LPL. - By conjugating fluorescent nanoparticle QDs to antigens and mixing the Ag-QD conjugate with a GNA-Ab composition, quenching of fluorescence upon binding of the antigen/antibody pair can be observed. The Ag and/or the Ab can be conjugated to the QD or GNA using a linker molecule (LM). A decrease in fluorescence can indicate the presence of the antibody for that particular antigen to which the fluorescing QDs have been attached. Depending on which antigen is utilized a wide array of antibodies can be detected. This can allow for the rapid detection of cancers or diseases that currently can take days or weeks to diagnose. Likewise, the scheme can work as well if antibody is attached to a fluorescent QD and the respective antigen to a metal nanoparticle. Metal particles have no florescence with visible excitation. The fluorescence quenching by metal nanoparticles can be more effective than quenching by larger QDs. This approach is sensitive and specific. The distance between the metal nanoparticle and QD is important for this to work (for example, the distance can be less than 2 nm). The interaction between the two components can be adjusted to achieve the maximum quenching effect.
- Surface-enhanced Raman scattering using silver nanoparticles was applied to detect various forms of lysophosphatidic acid (LPA) to examine its potential application as an alternative to current detection methods of LPA as biomarkers of ovarian cancer. Enhancement of the Raman modes of the molecule, especially those related to the acyl chain within the 800-1300 cm−1 region, was observed. In particular, the C—C vibration mode of the gauche-bonded chain around 1100 cm−1 was enhanced to allow the discrimination of two similar LPA molecules. Given the molecular selectivity of this technique, the detection of LPA using SERS may eliminate the need for partial purification of samples prior to analysis in cancer screening.
- Lysophosphatidic acid (LPA), originally known for its role as an intermediate in intracellular lipid metabolism, has now been recognized as an important multifunctional biological mediator that can elicit cellular responses including mitogenic and antimitogenic effects on the cell cycle, actin skeleton regulation, and cellular motility (see Tigyi et al. (1994) Proc. Nat. Acad. Sci. 91: 1908-1912; van Corven et al. (1989) Cell 59: 45-54; Ridley and Hall (1992) Cell 70: 389-399; and Zhou et al (1995) J. Biol. Chem. 270: 25549-25556). The involvement of LPA in inducing cell proliferation, migration and survival implicates it in the initiation and progression of malignant disease, and has been proposed as a sensitive biomarker for ovarian cancer (see Xu et al (1998) JAMA 280: 719-723; Mills and Moolenaar (2003) Nature Reviews 3: 582-591; Fang et al (2004) J. Biol. Chem. 279: 9653-9661; and Sutphen et al (2004) Cancer Epidemiol. Biomark. Prev. 13: 1185-1191).
- Typically, the detection of LPA has been conducted using chromatography and mass spectroscopy assays that require a partial purification of the samples using thin layer chromatography (TLC) prior to analysis. Although this method is effective, an underestimation of LPA concentration can result during the recovery process due in part to the varying mobility of the LPA salts (free acid, sodium and calcium salts) when subjected to chromatography by TLC. The low stability of LPA also calls for fast and sensitive detection techniques.
- A powerful optical detection technique based on surface-enhanced Raman scattering (SERS) offers a unique combination of high sensitivity and molecular specificity. With SERS, the Raman signal of a molecule is increased by many orders of magnitude as a result of strong enhancement of the excitation light through the resonance of the metal's surface electrons called the surface plasmon (see Moskovitz (1985) Rev. Modern Physics 57: 783-828; Otto et al. (1992) J. Phys. Condense Matter 4: 1143-1212; and Campion and Kambhampati (1998) Chem. Soc. Rev. 27: 241-250). SERS has been successfully used in the detection and analysis of a large number of chemicals and biological molecules (see Albrecht and Creighton (1977) J. Am. Chem. Soc. 99: 5215-5217; Nie and Emory (1997) Science 275: 1102-1106; Keating et al. (1998) J. Phys. Chem. B 102: 9414-9425; Kneipp et al (1998) Phys. Rev. E 57: R6281-R6284; and Schwartzberg et al. (2004) J. Phys. Chem. B 108: 19191-19197).
- Another application of SERS based on the gold nanoparticle system is for measuring Raman spectrum of semiconductor nanoparticles (QDs). Similar to molecules, normal Raman signals are very small and thus Raman spectrum is challenging to measure. SERS as an enhanced Raman technique for measuring Raman for semiconductor nanoparticles have not been reported before. The surface chemistry of the metal nanoparticles and the semiconductor QDs must be compatible for this to work. The sulfur species on the surface of the GNAs are ideal for II-VI SQDs to bind, enabling SERS detection of the SQDs. This provides a powerful method for detecting and analyzing semiconductor nanoparticles.
- Raman amplifiers have been used to amplify signal in optical communications (see, for example,
FIG. 6 ). SERS can provide more amplification than normal Raman amplifiers. By doping MNPs, for example GNAs, into glass or polymer fibers, Raman scattering from the glass or polymer matrix can be used to amplify optical signal with the proper wavelength. - Proteins or portions thereof may be produced not only by recombinant methods, but also by using chemical methods well known in the art. Solid phase peptide synthesis may be carried out in a batchwise or continuous flow process which sequentially adds α-amino- and side chain-protected amino acid residues to an insoluble polymeric support via a linker molecule. A linker molecule such as methylamine-derivatized polyethylene glycol is attached to poly(styrene-co-divinylbenzene) to form the support resin. The amino acid residues are N-α-protected by acid labile Boc (t-butyloxycarbonyl) or base-labile Fmoc (9-fluorenylmethoxycarbonyl). The carboxyl group of the protected amino acid is coupled to the amine of the linker group to anchor the residue to the solid phase support resin.
- Trifluoroacetic acid or piperidine are used to remove the protecting group in the case of Boc or Fmoc, respectively. Each additional amino acid is added to the anchored residue using a coupling agent or pre-activated amino acid derivative, and the resin is washed. The full-length peptide is synthesized by sequential deprotection, coupling of derivatized amino acids, and washing with dichloromethane and/or N,N-dimethylformamide. The peptide is cleaved between the peptide carboxy terminus and the linker group to yield a peptide acid or amide. These processes are described in the Novabiochem 1997/98 Catalog and Peptide Synthesis Handbook (San Diego Calif. pp. S1-S20). Automated synthesis may also be carried out on machines such as the ABI 431A peptide synthesizer (ABI). A protein or portion thereof may be purified by preparative high performance liquid chromatography and its composition confirmed by amino acid analysis or by sequencing (Creighton (1984) Proteins, Structures and Molecular Properties, W H Freeman, New York N.Y.).
- In particular, a purified antigen may be used to produce antibodies or to screen libraries of pharmaceutical agents to identify those that specifically bind an antigen. Antibodies to an antigen may also be generated using methods that are well known in the art. Such antibodies may include, but are not limited to, polyclonal, monoclonal, chimeric, and single chain antibodies, Fab fragments, and fragments produced by a Fab expression library. Neutralizing antibodies (i.e., those which inhibit dimer formation) are especially preferred for therapeutic use.
- For the production of polyclonal antibodies, various hosts including goats, rabbits, rats, mice, humans, and others may be immunized by injection with an antigen or with any fragment or oligopeptide thereof that has immunogenic properties. Rats and mice are preferred hosts for downstream applications involving monoclonal antibody production. Depending on the host species, various adjuvants may be used to increase immunological response. Such adjuvants include, but are not limited to, Freund's, mineral gels such as aluminum hydroxide, and surface-active substances such as lysolecithin, pluronic polyols, polyanions, peptides, oil emulsions, keyhole limpet hemacyanin (KLH), and dinitrophenol. Among adjuvants used in humans, BCG (bacilli Calmette-Guerin) and Corynebacterium parvum are especially preferable. (For review of methods for antibody production and analysis, see, for example, Harlow and Lane (1988) Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.)
- It is preferred that the oligopeptides, peptides, or fragments used to induce antibodies to an antigen have an amino acid sequence consisting of at least about 5 amino acids, and, more preferably, of at least about 14 amino acids. It is also preferable that these oligopeptides, peptides, or fragments are identical to a portion of the amino acid sequence of the natural protein and contain the entire amino acid sequence of a small, naturally occurring molecule. Short stretches of antigen amino acids may be fused with those of another protein, such as KLH, and antibodies to the chimeric molecule may be produced.
- Monoclonal antibodies to an antigen may be prepared using any technique that provides for the production of antibody molecules by continuous cell lines in culture. These include, but are not limited to, the hybridoma technique, the human B-cell hybridoma technique, and the EBV-hybridoma technique. (See, for example, Kohler et al. (1975) Nature 256: 495-497; Kozbor et al. (1985) J. Immunol. Methods 81: 31-42; Cote et al. (1983) Proc. Natl. Acad. Sci. 80: 2026-2030; and Cole et al. (1984) Mol. Cell Biol. 62: 109-120.)
- In addition, techniques developed for the production of “chimeric antibodies,” such as the splicing of mouse antibody genes to human antibody genes to obtain a molecule with appropriate antigen specificity and biological activity, can be used. (See, for example, Morrison et al. (1984) Proc. Natl. Acad. Sci. 81: 6851-6855; Neuberger et al. (1984) Nature 312: 604-608; and Takeda et al. (1985) Nature 314: 452-454.) Alternatively, techniques described for the production of single chain antibodies may be adapted, using methods known in the art, to produce antigen-specific single chain antibodies. Antibodies with related specificity, but of distinct idiotypic composition, may be generated by chain shuffling from random combinatorial immunoglobulin libraries. (See, for example, Burton (1991) Proc. Natl. Acad. Sci. 88: 10134-10137.)
- Antibodies may also be produced by inducing in vivo production in the lymphocyte population or by screening immunoglobulin libraries or panels of highly specific binding reagents as disclosed in the literature. (See, for example, Orlandi et al. (1989) Proc. Natl. Acad. Sci. 86: 3833-3837; and Winter et al. (1991) Nature 349: 293-299.)
- Antibody fragments that contain specific binding sites for an antigen may also be generated. For example, such fragments include, but are not limited to, F(ab′)2 fragments produced by pepsin digestion of the antibody molecule and Fab fragments generated by reducing the disulfide bridges of the F(ab′)2 fragments. Alternatively, Fab expression libraries may be constructed to allow rapid and easy identification of monoclonal Fab fragments with the desired specificity. (See, for example, Huse et al. (1989) Science 246: 1275-1281.)
- Various immunoassays may be used for screening to identify antibodies having the desired specificity and minimal cross-reactivity. Numerous protocols for competitive binding or immunoradiometric assays using either polyclonal or monoclonal antibodies with established specificities are well known in the art. Such immunoassays typically involve the measurement of complex formation between an antigen and its specific antibody. A two-site, monoclonal-based immunoassay utilizing monoclonal antibodies reactive to two non-interfering antigen epitopes is preferred, but a competitive binding assay may also be employed. (Maddox, supra.)
- Various methods such as Scatchard analysis in conjunction with radioimmunoassay techniques may be used to assess the affinity of antibodies for an antigen. Affinity is expressed as an association constant, Ka, which is defined as the molar concentration of antigen-antibody complex divided by the molar concentrations of free antigen and free antibody under equilibrium conditions. The Ka determined for a preparation of polyclonal antibodies, which are heterogeneous in their affinities for multiple antigen epitopes, represents the average affinity, or avidity, of the antibodies for an antigen. The Ka determined for a preparation of monoclonal antibodies, which are monospecific for a particular antigen epitope, represents a true measure of affinity. High-affinity antibody preparations with Ka ranging from about 109 to 1012 l/mole are preferred for use in immunoassays in which the antigen-antibody complex must withstand rigorous manipulations. Low-affinity antibody preparations with Ka ranging from about 106 to 107 l/mole are preferred for use in immunopurification and similar procedures which ultimately require dissociation of antigen, preferably in active form, from the antibody. (See Catty (1988) Antibodies, Volume I: A Practical Approach, IRL Press, Washington, D. C.; and Liddell and Cryer (1991) A Practical Guide to Monoclonal Antibodies, John Wiley & Sons, New York, N.Y.)
- The titre and avidity of polyclonal antibody preparations may be further evaluated to determine the quality and suitability of such preparations for certain downstream applications. For example, a polyclonal antibody preparation containing at least 1-2 mg specific antibody.ml−1, preferably 5-10 mg specific antibody.ml−1, is preferred for use in procedures requiring precipitation of antigen-antibody complexes. Procedures for evaluating antibody specificity, titer, and avidity, and guidelines for antibody quality and usage in various applications, are generally available. (See, for example, Catty, supra, and Coligan et al. supra.)
- Various hosts including, but not limited to, goats, rabbits, rats, mice, and human cell lines may be immunized by injection with antigen or any portion thereof. Adjuvants such as Freund's, mineral gels, and surface-active substances such as lysolecithin, pluronic polyols, polyanions, peptides, oil emulsions, KLH, and dinitrophenol may be used to increase immunological response. The oligopeptide, peptide, or portion of protein used to induce antibodies should consist of at least about five amino acids, more preferably ten amino acids, which are identical to a portion of the natural protein. Oligopeptides may be fused with proteins such as KLH in order to produce antibodies to the chimeric molecule.
- Monoclonal antibodies may be prepared using any technique that provides for the production of antibodies by continuous cell lines in culture. These include, but are not limited to, the hybridoma technique, the human B-cell hybridoma technique, and the EBV-hybridoma technique. (See, for example, Kohler et al. (1975) Nature 256:495-497; Kozbor et al. (1985) J. Immunol. Methods 81:31-42; Cote et al. (1983) Proc. Natl. Acad. Sci. 80:2026-2030; and Cole et al. (1984) Mol. Cell. Biol. 62: 109-120.)
- Alternatively, techniques described for antibody production may be adapted, using methods known in the art, to produce epitope-specific, single chain antibodies. Antibody fragments that contain specific binding sites for epitopes of the protein may also be generated. For example, such fragments include, but are not limited to, F(ab′)2 fragments produced by pepsin digestion of the antibody molecule and Fab fragments generated by reducing the disulfide bridges of the F(ab)2 fragments. Alternatively, Fab expression libraries may be constructed to allow rapid and easy identification of monoclonal Fab fragments with the desired specificity. (See, for example, Huse et al. (1989) Science 246: 1275-1281.)
- The antigen, or a portion thereof, may be used in screening assays of phagemid or B-lymphocyte immunoglobulin libraries to identify antibodies having the desired specificity. Numerous protocols for competitive binding or immunoassays using either polyclonal or monoclonal antibodies with established specificities are well known in the art. Such immunoassays typically involve the measurement of complex formation between the protein and its specific antibody. A two-site, monoclonal-based immunoassay utilizing monoclonal antibodies reactive to two non-interfering epitopes is preferred, but a competitive binding assay may also be employed (Pound (1998) Immunochemical Protocols, Humana Press, Totowa N.J.).
- In the alternative, an antibody can be substituted by, for example, a chimeric protein that comprises a portion or fragment of a T-cell receptor (TCR). TCRs have an immunoglobulin domain that binds a cell-surface antigen comprising a host or a non-host molecule. Such molecules can be of viral origin or can be a particular cancer marker protein. The chimeric protein can also comprise a soluble protein (i.e. present in a bodily fluid or the cell cytoplasm) or a cell membrane-associated protein (such as a ligand receptor, an ion channel, or a molecule involved in signal transduction.
- Metal nanoparticles are currently studied for a wide variety of biomedical applications including contrast imaging, ultrasonic imaging, thermal destruction of specific cancer cells, and laser tissue welding. All applications of this type rely on the optical and physical properties associated with metal nanoparticles, nominally of gold. Much of this work has focused on gold nanoshells due to their near IR optical absorption where tissue transmission is at its peak, making in-vivo applications feasible. This gold nanoparticle aggregate system possesses these same optical features with multiple advantages. While nanoshells can be tuned to absorb in a particular region, their absorption is inhomogenously broad and cannot be narrowed without significant purification. Therefore a significant percentage of nanoshells will be functionally useless at a given wavelength. Gold aggregates on the other hand can be tuned to have a very narrow absorption through the optical hole burning technique. With the absorption tuned to a given wavelength all aggregates will be utilized making them significantly more efficient for any of the above applications.
- One of the most exciting of these applications is thermal destruction of cancer cells. The nanoparticle aggregates are selectively attached to cancer cells in a tumor by a passive mechanism that has been termed an “enhanced permeability and retention effect”. The tumor mass is then illuminated with near IR laser light which passes harmlessly through the tissue, but is absorbed strongly by the aggregates, causing them to heat drastically, killing only the cancerous cells. (See O'Neal et al. (2004) Cancer Lett. 209: 171-176, herein incorporated by reference in its entirety.) This technology has been utilized with gold-silica nanoshells further comprising “stealthing” polymers, such as poly(ethyleneglycol) and derives thereof, or liposomes; however this can be done better with gold nanoparticle aggregates of the present invention.
- The nanoparticle aggregates can be used to detect specific compounds that may be at very low levels in a sample. Such a sample can be blood, urine, saliva, lung lavage, gastric fluid, lymphatic fluid, any other body fluid, or the like. In addition, the sample can be a sample of water or other aqueous medium, such as water from a spring, a stream, a river, a pond, a lake, a sea, or an ocean. The sample can be a geological sample such as from a geothermal spring, a lava evaporate or exudate, a hydrocarbon, or from an abyssal trench; a plant sample such as from the xylem or phloem of a stalk or trunk; a sample from a fluid in a man-made structure such as concrete, cement, aggregate, or the like; a sample of fluid from a piece of machinery such as an engine, motor, compressor, or the like.
- The nanoparticle aggregates can be conjugated with antibody, the antibody having been synthesized to bind a specific compound. Such a specific compound can be a protein, a fatty acid, a carbohydrate, an organic compound based upon a benzene ring structure, an organic compound based upon a short chain hydrocarbon, a medium chain hydrocarbon or a long chain hydrocarbon. The specific compound can be modified with a reactive group. Such reactive groups are well known to those of skill in the art and can include phosphate groups, methyl groups, hydroxyl groups, sulphate groups, acetyl groups, or the like.
- The nanoparticle aggregate-antibody conjugate complex has an altered SERS profile when the specific compound binds to the complex. The complex can be applied and incorporated onto a substrate surface of an optical fiber as disclosed herein. The exterior surface of the fiber comprises a compound that reflects photons. Such compounds are well known to those in the fiberoptic arts. The optical fiber has a proximal end or proximal section and a distal end or distal section. The distal end of a conventional fiber has a circular cross-section. A modified substrate surface can be created to create a substrate surface having an area larger than that of the distal end. The substrate surface of the fiber is created by removing a distal portion of the fiber section thereby creating a fiber with a distal end cross-section that is different from the distal end of the original fiber. The cross-section can be D-shaped, diamond-shaped, triangular, oval, or another non-symmetrical shape. Removing a portion of the fiber results in substrate surface with a larger surface area than the surface area of the original end of the fiber.
- The resulting substrate surface can have a surface area that is up to at least about 8,000-fold larger than the distal end surface of the original fiber. The diameter of the fiber can be from between about 0.01 μm to about 10 μm. In one alternative, the diameter is from between about 0.1 μm to about 1 μm. In another alternative, the diameter is between about 0.2 μm to about 8 μm.
- The complex is applied and incorporated onto the substrate surface and light is directed longitudinally through the fiber. The light can be coherent and/or non-coherent. The light interacts with the nanoparticle aggregate-antibody conjugate complex and a resulting SERS profile can be compared with a SERS profile from the nanoparticle aggregate-antibody conjugate complex that is bound with a known amount of specific compound. The SERS radiation is detected using a photon detector suitably disposed to detect the SERS radiation. The detector can be disposed at or near the substrate surface of the fiber at the distal end or distal section of the fiber, at or near the proximal end or proximal section of the fiber, or at another position as disclosed herein.
- The fiber can have one or more such substrate surfaces. In the case of two substrate surfaces, the second substrate surface can reflect the SERS signal from the first substrate surface to the detector longitudinally along the length of the fiber, resulting in a markedly improved amplification of the SERS signal. Similarly, the first substrate surface can reflect a SERS signal from the second substrate surface to the detector.
- In another alternative, at least one additional optical fiber can be positioned in proximity to the distal end or distal section of the fiber. The end of the additional fiber can have the same shape as the shape of the distal end or distal section of the fiber, such that SERS radiation emitted from the fiber is conducted through the additional fiber to a detector. Two additional fibers can be used in parallel where there are two new substrate surface s on the fiber.
- The optical fiber can additionally have a non-uniform diameter, for example, the distal end having a cross-section perpendicular to the longitudinal plane that is larger in magnitude than a cross-section of the proximal end. Such a shape can further increase the amount of SERS radiation produced by a photon source.
- The optical fiber can be made using glass, ceramics, or the like; or a polymeric compound such as cyclic olefin polymer (COP), polysulfone (for example, UDEL and RADEL resins), fluorinated terpolymers (such as those synthesized from tertafluoroethylene, hexafluoropropylene, and vinylidene fluoride), polycarbonate, polyacrylate, polystryrene, or the like.
- As illustrated in
FIG. 13 , the surface of the substrate surface (2) of the fiber (1) is at an angle θ (7) to the longitudinal plane (8) of the fiber. The angle θ is between 15° and 75°; preferably between 15° and 65°; more preferably between 15° and 45°; and most preferably between 15° and 35°. In one example, the angle θ is 22.5°. The optimal preferable angle can be determined empirically to find the optimal angle for back-scattering of the SERS radiation. - One of skill in the art can readily determine which angle θ is optimal using data collected from experimentation as described above and knowledge of the composition of the fiber. It is well known in the art that different compositions have different refractive indices and one of skill in that art would know that different compositions will have a particular optimal refractive index. One of skill in the art would also know that it is not always necessary to create a fiber having a distal end section having a substrate surface at the optimal angle θ to the plane of the fiber since the nanoparticle aggregate-antibody conjugate complex can have different effects upon the refractivity of a fiber compound. It would require relatively little experimentation by one of skill in the art to determine the optimal preferable angle θ.
- The SERS radiation can be further enhanced approximately 4-5-fold if an electrical field of a few Volts per centimeter (V/cm) is applied across the fiber, approximately perpendicular to the substrate surface. The potential difference can be maintained through an electrically conducting solution. The electrically conducting solution can be aqueous or non-aqueous but should not quench SERS radiation to the extent that the SERS enhancement due to the electrical field is quenched by the electrically conducting solution.
- Examples of different optical fiber ends are illustrated in
FIGS. 7 through 12 .FIG. 7A illustrates a cylindrical fiber (1) having an exterior surface (3) and having a longitudinal portion removed from the distal section of the fiber thereby creating a substrate surface (2).FIG. 7B shows a cross-section of the distal section. -
FIG. 8A illustrates an alternative distal section whereby a longitudinal portion is removed from the fiber at an included plane to the fiber resulting in a tapered distal end of the fiber.FIGS. 8B , 8C, and 8D illustrate three cross-sections of the distal section at different positions along the length of the fiber.FIG. 9 illustrates the path of a photon (4) from a photon source and the path of a SERS photon (5) from the substrate surface of the fiber to a detector (6). -
FIG. 10A illustrates another alternative distal section whereby two longitudinal portions are removed from the fiber resulting in a tapered distal end of the fiber.FIGS. 10B , 10C, and 10D illustrate three cross-sections of the distal section at different positions along the length of the fiber.FIG. 11 illustrates the path of a photon (4) from the photon source and the path of a SERS photon (5) from the substrate surface (2) of the fiber to a detector (6). -
FIG. 12 illustrates the distal end of a fiber positioned in proximity to the ends of two additional fibers that transmit the SERS photon to a detector.FIG. 13 illustrates the angle between the substrate surface (2) and the longitudinal plane (8) or axis of the fiber. - The nanoparticle aggregates can be formed and shaped into a desired shape, such as a sphere, a cylinder, a rod, a cone, a pyramid, or other shape, not limited to regular shapes, and deposited upon a substrate at a desired density using means well known t to hose of skill in the art. (See, for example, Fan et al. (2005) J. Vac. Sci. Technol. 8: 947-953; Chaney et al. (2005) Appl. Phys. Lett. 87: pub. no. 031908.)
- The invention will be more readily understood by reference to the following examples, which are included merely for purposes of illustration of certain aspects and embodiments of the present invention and not as limitations.
- The synthesis of the gold nanoparticle aggregates (GNAs) was performed as follows: 400-600 ul of a 0.02 M HAuCl4 stock solution was diluted to 4×10−4-6×10−4 M with Milli-Q water in glassware cleaned in aquaregia and rinsed with Milli-Q water to avoid contamination. To this, 40-60 μl of a 0.1 M solution of Na2S that has been aged for 2-3 months was added. After approximately 60-120 minutes, the color changed from a straw yellow to deep purple with the extended plasmon band (EPB) growing in between 600-1000 nm, indicating reaction completion. The aggregate formation was signified by strong near-infra-red (NIR) absorption at wavelengths longer than 600 nm. This reaction is also performed with sodium thiosulfate (Na2S2O3) by replacing 1:1 the sodium sulfide solution, however, while these particles are optically identical to those that are sodium sulfide generated, they work poorly for SERS and should only be used for non detection applications. HAuCl4, Na2S, Na2S2O3 and were obtained from Sigma-Aldrich (St. Louis Mo.) at the highest level of purity available.
- The coating of gold nanoparticle aggregates onto a substrate/fiber was performed in two ways. First, by spin coating or drop casting a dilute solution of the aggregates onto the substrate. This yields a relatively thick film, however, it is not as stable as is necessary for many applications. The second method utilizes a tethering molecule, in this case trimethoxy[3-(methylamino)propyl]silane (APS). The substrate was cleaned prior to the silanization step by sonication in 2% solution of HELLMANEX or other surfactant, followed by 18 mΩ water.
- The gold nanoparticle aggregates were then submerged in a 5 mM aqueous solution of APS to deposit the tethering molecules. After 1-2 minutes the substrate was rinsed with water, dried under nitrogen, and 40 μl of the aggregate solution was placed on the surface. After several seconds exposed to the solution, it was blown dry with nitrogen. This provided a significantly thinner film than those made by spin or drop casting, however, it was extremely stable and robust under use. This film was made to near monolayer coverage by increasing the substrate exposure time to the APS and aggregate solutions to approximately 1 hour. APS was obtained from Sigma-Aldrich.
- The extended plasmon band of the gold nanoparticle aggregates were tuned and narrowed via a regeneratively amplified, mode locked femtosecond Ti-sapphire laser system. This was done by illuminating the sample with the amplified femtosecond beam at a flux of approximately 0.1 mJ/cm2. After approximately 1 hour, a deep, broad hole was burned in the absorption spectrum at near 800 nm while absorption to the blue drastically increased.
- In order to tune the band to one particular wavelength a tunable picosecond laser is required. Due to the broad spectral linewidth of the femtosecond pulses it is impossible to completely narrow the extended plasmon band (EPB). By using the spectrally narrow picosecond pulses it is possible to selectively destroy the EPB to the blue and red of the desired excitation wavelength, enhancing the absorption more than two fold.
- Samples for single particle experiments were prepared by immobilizing the GNAs or semiconductor quantum dots (SQD) on glass coverslips with trimethoxy[3-(methylamino)propyl]silane (APS). Coverslips were cleaned prior to the silanization step by sonication in 2% solution of Hellmanex, followed by 18 MΩ water. They were then submerged in 5 mM aqueous solution of APS to deposit the tethering molecules. After 1-2 minutes the coverslips were rinsed with water, dried under nitrogen, and 40 μl of the aggregate or SQD solution was placed on one surface. After several seconds exposed to the solution, it was blown dry with nitrogen.
- Single particle experiments were performed on a custom designed confocal microscope built onto an inverted fluorescence microscope (Axiovert 100, Carl Zeiss, Inc., Thornwood N.Y.). A helium-neon or Argon ion laser depending on desired excitation wavelength was coupled into the back port of the microscope and directed into a high numerical aperture objective (Apochromat 100×, 1.4 NA) that focused the light onto the sample surface. The sample was then raster scanned across the focused laser to generate an image using a commercially available piezoelectric scanner (Physik Instrumente, Auburn Mass.) and control electronics (Digital Instruments (Veeco Instruments Inc.) Woodbury N.Y.). The Raman scattered light or fluorescence was collected with the same objective used for excitation and focused onto a confocal aperture. The Rayleigh scattered light was then removed using a holographic notch filter (Kaiser Optical Systems, Inc., Ann Arbor Mich.) and the remaining scattered light was focused onto an avalanche photodiode (EG&G (ClTY STATE)). Once a nanoparticle aggregate or QD was located, it was centered on the focused laser and the Raman scattering was directed into a spectrograph (Acton Instruments, Acton Mass.) that dispersed the light onto a liquid nitrogen cooled CCD camera (Princeton Instruments, Trenton N.J.). Typically six spectra (30 seconds each) were averaged. Bulk SERS experiments were performed on a Renishaw MICRORAMAN instrument (Renishaw Plc, Wotton-under-Edge, GL12 8JR, United Kingdom) with a 783 nm diode excitation laser. A drop of sample was placed on a quartz substrate and the laser was focused into the solution. Typically 4 spectra (30 seconds) were averaged.
- Lysophosphatidic acid (LPA), originally known for its role as an intermediate in intracellular lipid metabolism, has now been recognized as an important multifunctional biological mediator that can elicit cellular responses including mitogenic and antimitogenic effects on the cell cycle, actin skeleton regulation, and cellular motility. The involvement of LPA in inducing cell proliferation, migration and survival implicates it in the initiation and progression of malignant disease, and has been proposed as a sensitive biomarker for ovarian cancer.
- Typically, the detection of LPA has been conducted using chromatography and mass spectroscopy assays that require a partial purification of the samples using thin layer chromatography (TLC) prior to analysis. Although this method is effective, an underestimation of LPA levels can result during the recovery process due in part to the varying mobility of the LPA salts (free acid, sodium and calcium salts) when subjected to chromatography by TLC. The low stability of LPA also calls for fast and sensitive detection techniques.
- A powerful optical detection technique based on surface-enhanced Raman scattering (SERS) offers a unique combination of high sensitivity and molecular specificity. With SERS, the Raman signal of a molecule is increased by many orders of magnitude as a result of strong enhancement of the excitation light through the resonance of the metal's surface electrons called the surface plasmon. SERS has been successfully used in the detection and analysis of a large number of chemicals and biological molecules.
- Here we report for the first time to our knowledge, the application of SERS using silver nanoparticles as a potential alternative technique for detecting LPA with high sensitivity and molecular specificity. Experimental results obtained for 16:0 LPA and 18:0 LPA successfully demonstrated not only that SERS of LPA can be measured but also that the SERS spectra of the two very similar LPA molecules were shifted enough in the 1100 cm−1 region to uniquely identify them. The results suggested the strong potential for practical LPA detection using SERS-based techniques that are fast, sensitive, and molecular specific.
- Powder samples of 16:0 LPA (1-Palmitoyl-2-hydroxy-sn-glycero-3-phosphate(sodium salt)) and 18:0 LPA (1-Stearoyl-2-hydroxy-sn-glycero-3-phosphate(sodium salt)) were purchased from Avanti Polar Lipids, Inc. Silver nitrate and sodium citrate were purchased from Sigma Aldrich (St Louis Mo.). Raman spectra were obtained using a Renishaw micro-Raman setup with a 50× objective lens and 780 nm excitation laser at 3 mW.
- Silver nanoparticles were prepared using a synthesis from Lee and Meisel using silver nitrate as the metal precursor and a sodium citrate reducing agent (Lee and Meisel (1982) J. Phys. Chem. 86: 3391-3395). Formation of the silver nanoparticles was monitored using UV-visible spectroscopy using a HP 8452A spectrometer with 2 nm resolution. This nanoparticle solution was then concentrated by a factor of 10 via centrifugation prior to application. For the SERS experiment, 2 μl drops of the concentrated silver nanoparticles were placed on a glass slide and allowed to dry. Its Raman signal was obtained with one accumulation of a 30 second scan. After the silver had dried, 4 μl of a 100 μM solution of either the 16:0 LPA or 18:0 LPA (dissolved in Milli-Q water) was added on top of the silver to dry. The 4 μl volume ensured the complete coverage of the silver that had dried on the glass. The Raman signal was then collected using the same scan parameters. For comparison, Raman of the crystalline LPA samples was collected with five accumulations of a two-minute scan.
- The primary goal of this work was to demonstrate the ability of SERS to be selective, reproducible, and sensitive in detecting 16:0 LPA versus 18:0 LPA and show its potential as a viable alternative to current detection methods.
FIG. 14 presents the UV-vis absorption spectrum of the silver nanoparticles used in this experiment. The surface plasmon band of these particles peaks near 400 nm, and contains very weak absorption around 780 nm, possibly due to some nanoparticle aggregation. For SERS to work effectively, resonance absorption of the metal nanoparticle substrate with the incident wavelength is essential (Schwartzberg et al. (2004) supra). The fact that there is only weak absorption near 780 nm while SERS has been demonstrated to work effectively suggests that either the weak absorption at 780 nm is enough for SERS occur, or the nanoparticles have further aggregated upon concentrating and drying for the SERS experiment that may have caused a red-shift of the absorption band and increased absorption at 780 nm similar to what has been observed for gold nanoparticles (Norman et al. (2002) J. Phys. Chem. B 106: 7005-7012). - The Raman spectra and molecular structures of the bulk crystal of 16:0 LPA and 18:0 LPA are presented in
FIG. 15 andFIG. 16 , respectively. With the only difference between the two LPAs being the length of their acyl chains, the ability to apply SERS for detection applications depends on its capacity to detect the acyl peaks. Hence, experimental measurements were performed between 800-1400 cm−1 where many of the acyl peaks occur. The vibrational modes were assigned based on characteristic Raman frequencies (Lin-Vien et al. (1991) In: Infrared and Raman Characteristic Frequencies of Organic Molecules. Academic Press, Inc, San Diego Calif.). The band at 889 cm−1 is representative of methylene rocking, and the 1294 cm−1 band is typical of methylene twisting. The C—C skeletal stretching vibrations appeared between 1060 cm−1-1130 cm−1. In this region, information about the conformation of the carbon chain can also be obtained. The bands observed around 1060 cm−1 and 1130 cm−1 are characteristic of trans bonded carbon and the band observed around 1100 cm−1 denotes the vibration of a gauche bonded chain. The analysis of the spectra obtained for these LPA samples compared well to Raman spectra of various lipids that have been previously analyzed (Dai et al (2005) Colloids and Surfaces B 42: 21-28; Krafft et al. (2005) Spectrochim. Acta (61): 1529-1535; Saint-Pierre Chazelet et al. (1994) Thin Solid Films 244: 852-856; and Suh (1992) Chem. Phys. Lett. 193: 327-330). Very strong similarities between the spectra of these two LPA molecules were noted, in particular the 889 cm−1, 1294 cm−1, 1060 cm−1, and 1128 cm−1 bands that they commonly share. Fortunately, the 16:0 LPA was distinguishable from the 18:0 LPA by the shift of the C—C vibration of the gauche-bonded chain from 1097 cm−1 for 16:0 LPA to 1101 cm−1 for 18:0 LPA. -
FIG. 17 presents the SERS spectra of the two LPA samples that were dried on the silver nanoparticles after subtracting the background signal of the dried nanoparticle solution. Attempts to obtain the Raman spectra of dried samples of LPA solutions without any silver present resulted in no signal, indicating that the presence of the silver enhanced the LPA Raman signal and made the detection of low concentrations possible. As expected, the bands of the acyl chain were enhanced using this technique with little to no shift from their bulk Raman positions. The SERS signal of the 16:0 LPA maintained its peaks of 889 cm−1, 1097 cm−1, 1128 cm−1, and 1294 cm−1, while 18:0 LPA maintained its peaks of 889 cm−1, 1101 cm−1, 1128 cm−, and 1294 cm−1.FIG. 18 shows the region between 1050 cm−1-1130 cm−1, demonstrating the ability of this procedure to detect the gauche peak that allows the acyl chains of the LPA samples to be distinguished from each other is clearly observed. - In SERS, the relative enhancement of a given mode implies the preferred orientation of the adsorbate to the surface of the metal. Typically, enhancement of a given mode is best when it is closest to the surface of the metal. Comparing the band intensities of the SERS spectrum of either LPA sample to its respective bulk spectrum shows that the two are quite similar (see Table 1). In other words, the intensity distribution of the SERS modes of 16:0 LPA exhibited a similar pattern of its bulk spectrum. The same pattern was observed for the 18:0 samples. This implied that no strong attraction was occurring between the nanoparticle surface and functional groups on the molecule to promote a specific orientation of the adsorbate. Also, with any strong surface interaction between the adsorbate and metal present, one would expect a shift in some bands of the SERS spectrum compared to the bulk Raman spectrum due to vibrational hindrance that would result from the adsorbate-metal surface interaction. This phenomenon was not observed in the LPA SERS spectra. The conclusion that no strong interaction was present between the metal surface and adsorbate could also be made from the fact that no immediate SERS was observed for mixed solutions of silver and LPA. The interaction between LPA and the nanoparticle surface was only strong enough for SERS to be observed when the molecule was dried on top of the silver.
-
TABLE 1 Comparison of the intensity of the assigned vibrational modes of the Raman spectrum of the bulk samples of LPA with its SER signal (W = weak, M = medium, S = strong, VS = very strong) 16:0 18:0 18:0 Mode (cm−1) Assignment LPA 16:0 SERS LPA SERS 889 CH2 rock M M M M 1060 C—C vib (trans) S — S — 1097 or 1101 C—C vib (gauche) M M M M 1128 C—C vib (trans) S S VS VS 1294 CH2 (twist) S W VS M - Experiments to improve the sensitivity of this technique in terms of its ability to detect lower concentrations of various LPA in mixed samples along with actual samples of plasma/blood where other lysophospholipids besides LPA are present are performed. Some preliminary experiments using a prepared sample of mixed 16:0 and 18:0 LPA solutions had shown that this technique was able to distinguish the two different LPA molecules from each other in millimolar concentrations. However, in order to apply SERS for practical LPA detection, this technique should detect in micromolar quantities. As the surface interaction between the molecule and the nanoparticles play an important role in the effective enhancement of this technique, experiments are conducted with other metal nanoparticles capped with various surface agents that may induce stronger interactions between the acyl chain of the adsorbate and metal. We also can apply SERS detection of LPA using different shaped metal nanoparticles, as non-spherical particles with sharp edges or corners show stronger SERS activities than spherical particles (Schatz (1984) Acc. Chem. Res. 17: 370-376; Gersten (1980) J. Chem. Phys. 72: 5779-5780).
- The effect of binding an antigen to its antibody is observed by taking the Raman spectrum of the antibody before and after exposure to the antigen through the use of SERS. To study the applicability of this method, a primary antibody (SC2020, Santa Cruz Biotechnology Santa Cruz Calif.) and a secondary antibody (SC1616, Santa Cruz Biotechnology Santa Cruz Calif.) were used. SC2020 was obtained at a concentration of 400 μg/ml and diluted by a factor of two with 20 mM HEPES buffer (pH 7.4). This solution was mixed equal volume with a GNP solution that was also diluted by a factor of two with 20 mM HEPES buffer. After twenty minutes of interaction, a SERS spectrum was obtained. An equal amount of SC1616 was added to the system and the SERS spectrum was obtained again. The binding of the secondary antibody (SC1616) to the primary antibody (SC2020) caused the SERS intensity of the secondary antibody to increase by 20-50%. This method provides an indirect means of detecting antigens in a system.
- A murine monoclonal antibody raised against the CA125 ovarian cancer marker (OC125; Bast et al. (1981) J. Clin. Invest. 68: 1331-1337; Cat. No. AB19551, AbCam Ltd., Cambridge, UK) is incubated at a final concentration of 100 μg/ml in HEPES buffer (pH 7.4) with GNA as prepared above at a final concentration of 1 mg/ml for twenty minutes at ambient temperature. The mixture is then washed four times with excess sample buffer, then stored at 4° C. until use. A fraction is subjected to SERS to obtain baseline values.
- Fluid samples from individuals with diagnosed ovarian cancer are incubated with SQD in the presence of a conjugating agent and linker molecule for 20 minutes at ambient temperature. The mixture is washed four times and resuspended in HEPES buffer (pH 7.4) to produce SQD-Ag conjugate. A fraction is subjected to SQD luminescence to obtain baseline values.
- The SQD-Ag conjugate is added to OC125-GNA mixture in HEPES incubation medium (pH 7.4) at ambient temperature for 8 hours. Control samples are from individuals without diagnosed disease or disorders. The samples are then washed four times with incubation medium, resuspended in sample buffer, and then divided into two fractions. One fraction is subjected to SQD luminescence. The other fraction is subjected to SERS. Baseline values obtained earlier are then compared with the values obtained under experimental conditions.
- Antigen substantially purified using polyacrylamide gel electrophoresis (PAGE; see, for example, Harrington (1990) Methods Enzymol. 182: 488-495) or other purification techniques is used to immunize rabbits and to produce antibodies using standard protocols. The antigen amino acid sequence is analyzed using DNASTAR software (DNASTAR Inc., Madison Wis.) to determine regions of high immunogenicity, and a corresponding oligopeptide is synthesized and used to raise antibodies by means known to those of skill in the art. Methods for selection of appropriate epitopes, such as those near the C-terminus or in hydrophilic regions are well described in the art. (See, for example, Ausubel et al. supra,
chapter 11.) - Typically, the oligopeptides are 15 residues in length, and are synthesized using an Applied Biosystems Peptide Synthesizer Model 431 A using Fmoc-chemistry and coupled to KLH (Sigma-Aldrich, St. Louis, Mo.) by reaction with N-maleimidobenzoyl-N-hydroxysuccinimide ester to increase immunogenicity. (See, for example, Ausubel et al. supra.) Rabbits are immunized with the oligopeptide-KLH complex in complete Freund's adjuvant. Resulting antisera are tested for antipeptide activity, for example, by binding the peptide to plastic, blocking with 1% BSA, reacting with rabbit antisera, washing, and reacting with radio-iodinated goat anti-rabbit IgG. In the alternative, a non-peptide antigen is used and is conjugated to KLH.
- Naturally occurring or recombinant antigen is substantially purified by immunoaffinity chromatography using antibodies specific for the antigen. An immunoaffinity column is constructed by covalently coupling anti-antigen antibody to an activated chromatographic resin, such as CNBr-activated Sepharose (Pharmacia & Upjohn, Kalamazoo Mich.). After the coupling, the resin is blocked and washed according to the manufacturer's instructions.
- Media containing antigen are passed over the immunoaffinity column, and the column is washed under conditions that allow the preferential absorbance of antigen (for example, high ionic strength buffers in the presence of detergent). The column is eluted under conditions that disrupt antibody/antigen binding (for example, a buffer of
pH 2 topH 3, or a high concentration of a chaotrope, such as urea or thiocyanate ion), and antigen is collected. - Antigen, or biologically active fragments thereof, are labeled with [125I] Bolton-Hunter reagent. (See, for example, Bolton and Hunter (1973) Biochem. J. 133: 529-539.) Candidate molecules previously arrayed in the wells of a multi-well plate are incubated with the labeled antigen, washed, and any wells with labeled antigen complex are assayed. Data obtained using different concentrations of antigen are used to calculate values for the number, affinity, and association of antigen with the candidate molecules.
- Fiber surface enhanced Raman scattering (SERS) sensors show great potential for in vivo and in vitro detection, however, current probes based on end polished fibers suffer from small signal due to their small active region. To overcome this, we propose and demonstrate a D-shaped fiber configuration to increase the detection area. Initial modeling has shown that most of the light can be absorbed by the SERS active layer coated on the polished fiber surface. Several orders of magnitude increase in surface area leads to substantially more detectable Raman scattered photons than those in end tip configurations. The SERS sensor based on D-shaped fibers has been demonstrated, for the first time, with excellent results using rhodamine 6G.
- The majority of previous work in this area has utilized colloidal solutions or single use films to great effect, however, for practical applications the substrate must be portable, reusable, and robust (see Schwarzberg et al. (2004) supra; Tao et al. (2003) Nano Letters 3: 1229; van Duyne (2002) Abstracts of Papers of the American Chemical Society 223: 3; Sagmulleret al. (2003) J. Mol. Struct. 661: 279; Michaels et al. (2000) J. Phys. Chem. B 104: 11965; and Jana (2003) Analyst 128: 954). Recently, significant advancements have been made to this end. End tip fiber optic SERS probes have been shown to produce excellent results with high stability and portability, where a fiber with a flat, angled, or tapered tip was modified with silver island films, roughened silver films, or silver film over nanospheres to produce the SERS substrate (see Stokes et al. (2004) Applied Spectroscopy 58: 292; Stokes and Vo-Dinh (2000) Sensors and Actuators B-Chemical 69: 28; Mullen and Carron (1991) Anal. Chem. 63: 2196; Gessner et al. (2004) Analyst 129: 1193; Viets and Hill (1998) Sensors and Actuators B-Chemical 51: 92; Viets and Hill (2000) J. Raman Spectrosc. 31: 625; and Viets and Hill (2001) J. Mol. Struct. 565: 515). This configuration is highly advantageous, being reproducible, facile to fabricate, and inexpensive. The main limitation is the small number of SERS particles on the active fiber region, requiring high laser intensity and long integration times to attain reasonable SERS spectrum.
- To overcome this hurdle, we chose to use a D-shaped fiber (DSF) configuration, so named because of the cross sectional D-shape formed by side polishing the fiber (see
FIG. 19 ). Light can be coupled out of the polished fiber into silver or gold nanostructured films coated onto the polished surface, which can potentially increase the active surface area by several orders of magnitude. DSF has been used in a variety of applications including humidity, temperature, strain sensing, communication, optical switching, attenuators, and polarizers, but never for SERS detection, to our knowledge (see McCallion and M. Shimazu (1998) Laser Focus World 34: S19; Sohn et al. (2002) Sensors and Actuators A-Physical 101: 137; Alvarez-Herrero et al. (2000) IEEE Photonics Technol. Lett. 12: 1043; and Gu et al. (2003a) J. Optics A-Pure Appl. Optics 5: S420; Gu et al. (2003b), Optical Materials 23: 219). - Procedures for polishing the DSF have been described previously (Xu (2003) In-line fiber optical components for telecommunication in electrical engineering, University of California, Santa Cruz, Santa Cruz, Calif.). The surface of the flat polished plane was purposely left rough to facilitate nanoparticle binding and increase active surface area. Silver nanoparticles were synthesized by the method of Lee and Meisel (Lee and Meisel (1982) J. Phys. Chem. 86: 3391).
- The SERS fibers were created by mixing 20 μl of silver nanoparticles with 5 μl of 0.1 mM rhodamine 6G (R6G) and drying a drop of this solution on the fiber under ambient conditions. SERS experiments were then performed on these devices in two configurations. A 780 nm diode laser is either coupled into the fiber (
FIG. 19 ) or into a Renishaw micro-Raman spectrometer with a 20× objective. In both configurations the micro-Raman spectrometer collects the scattered light from the DSF. Samples were nominally integrated for 40 seconds for one scan with a laser intensity of ˜3 mW. - On a highly polished DSF, little or no light would be coupled out of the fiber core. When the surface is roughened and coated with a layer of metal such as silver nanoparticles, light can be coupled into the coating layer to induce SERS. The amount of light coupled into the film is determined by several parameters including polishing depth, film thickness and density, and nature of the metal. The proper polishing depth should be determined by calculation, however, drop-casting a silver nanoparticle film onto the DSF ensures a thick coating which will couple the maximum amount of light from the fiber core into the SERS substrate.
- To determine how the light will be coupled out of the fiber into the SERS substrate, we simulated light propagation inside a D-shaped fiber covered with a solid silver film as the colloidal film, using FIMMWAVE software. Various film thickness, polishing depth, refractive index, and absorption constants were used in our simulation. We found that the amount of light being coupled into the metal layer strongly depends on the refractive index and the absorption constant of the metal. As an example,
FIG. 20 shows the simulation result of a Corning 28e fiber covered with a silver nanoparticle aggregate layer. The plot inFIG. 20 shows the intensity distribution across the polished surface (top view illustrated). The fiber parameters were: core diameter 48 μm, ncore=1.450, cladding diameter 125 μm, nclad=1.4447, and the polished surface cuts through the center of the fiber core. The metal film parameters were: thickness=0.1 μm, nAg=0.147, αAg=82000/cm. Here a large absorption constant was chosen because of the resonant absorption of the Ag nanoparticle aggregates at 780 nm wavelength. With this choice of parameters, as light propagated through the side-polished section (from left to right inFIG. 20 ), the total intensity decreased due to coupling into the metal film and metal absorption, with only 30% remaining in the core at the end of the 1 cm side-polished fiber segment. The absorbed light activated SERS scattering over the entire 1 cm×8 μm=80,000 μm2 surface region above the fiber core, as opposed to the 50 μm2 of an end polished fiber of the same kind. As shown in the inset ofFIG. 20 , within a cross-section perpendicular to the fiber axis, light was mostly confined in the core region. Utilizing the DSF would increase the SERS active area, and consequently Raman scattered light, by as much as three orders of magnitude since light can be coupled into the metal layer over a substantial distance. - Having confirmed the viability of the concept, SERS experiments were conducted using rhodamine 6G as a reference molecule resulting in excellent SERS data. With the laser coupled through the microscope and aligned perpendicular to the DSF surface, large enhancements are observed in the Raman modes of rhodamine 6G (
FIG. 21 , B). As expected, all peaks observed in the SERS spectrum were consistent with previous SERS results of rhodamine 6G (see Hildebrandt and Stockburger (1984) J. Phys. Chem. 88: 5935). More interestingly, instead of coupling light through the Raman optical microscope, light coupled into the fiber from the end of the fiber (seeFIG. 19 ) produced similarly intense signals emitted and detected from the DSF surface (FIG. 21 , A). In this case, light coupled from the core of the fiber into the silver nanoparticle film on the surface activates the plasmon mode and induced SERS of R6G on the film. It is important to note that after background subtraction the SERS spectra measured from both configurations were completely consistent. While peak intensities vary slightly, peak positions remained nearly constant. This indicated that the scattering mechanism was the same, independent of the excitation configuration. - One should be careful when comparing these spectra since their excitation intensities are different. The intensity of illumination through the microscope objective was high and confined to a small area due to the strong focusing of the excitation beam. The light coupled through the fiber had lower intensity over a larger area. Excitation intensity and surface area affect the scattering strength. The variations of peak intensities in the two spectra collected using two different illumination configurations could be partly due to the difference in excitation intensity.
- In conclusion, we proposed and demonstrated a SERS sensor based on D-shaped fibers. Initial modeling had shown that as much as 70% of light coupled into the fiber may be absorbed into the SERS active layer across much of the 1 cm×8 μm surface, yielding an 80,000 μm2 active region for a D-shaped fiber as compared to ˜50 μm2 of an end polished fiber of the same kind. This leads to as much as three orders of magnitude increase in Raman scattered photons compared to end tip fiber probes. The device was tested with rhodamine 6G with light directly illuminating the fiber surface and coupled through the fiber. Both configurations yield excellent and consistent SERS spectra of R6G. The experimental results, in conjunction with the theoretical modeling, demonstrated successfully that D-shaped fibers can serve as a convenient platform for SERS sensors that can potentially provide extremely high sensitivity and molecular specificity.
- Those skilled in the art will appreciate that various adaptations and modifications of the just-described embodiments can be configured without departing from the scope and spirit of the invention. Other suitable techniques and methods known in the art can be applied in numerous specific modalities by one skilled in the art and in light of the description of the present invention described herein. Therefore, it is to be understood that the invention can be practiced other than as specifically described herein. The above description is intended to be illustrative, and not restrictive. Many other embodiments will be apparent to those of skill in the art upon reviewing the above description. The scope of the invention should, therefore, be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled.
Claims (30)
1. A chemical sensor comprising a plurality of particles, each particle comprising: a core, a shell having at least one surface and having contact with the core and wherein the shell comprises a sulfur-oxygen molecular species, and wherein the particle has been selectively sized using a notch filter and electromagnetic radiation, the electromagnetic radiation having a spectral wavelength of between about 350 nm and about 1075 nm.
2. The chemical sensor of claim 1 wherein the core comprises a metal selected from the group consisting of gold, silver, platinum, copper, aluminum, palladium, cadmium, iridium, and rhodium.
3. The chemical sensor of claim 1 wherein the core comprises gold.
4. The chemical sensor of claim 1 wherein the shell that further comprises a linker molecule, the linker molecule selected from the group consisting of a thiol group, a sulphide group, a phosphate group, a sulphate group, a cyano group, a piperidine group, an Fmoc group, and a Boc group.
5. The chemical sensor of claim 1 wherein the electromagnetic radiation has a spectral wavelength of between about 350 nm and about 650 nm and between about 950 nm and about 1075 nm.
6. The chemical sensor of claim 1 wherein the electromagnetic radiation has a spectral wavelength of between about 350 nm and about 775 nm and between about 875 nm and about 1075 mn.
7. The chemical sensor of claim 1 wherein the particle has a size in the range of about 60 and 200 nm.
8. The chemical sensor of claim 1 further comprising a support.
9. The chemical sensor of claim 8 wherein the support comprises a medium that is permeable to an analyte of interest.
10. The chemical sensor of claim 1 wherein the surface can induce surface enhanced Raman scattering.
11. The chemical sensor of claim 1 further comprising a detecting molecule, wherein the detecting molecule is bound to the surface.
12. The chemical sensor of claim 11 wherein the detecting molecule is selected from the group consisting of proteins, peptides, antibodies, antigens, nucleic acids, peptide nucleic acids, sugars, lipids, glycophosphoinositols, and lipopolysaccharides.
13. The chemical sensor of claim 11 wherein the detecting molecule is an antibody.
14. The chemical sensor of claim 11 wherein the detecting molecule is an antigen.
15. The chemical sensor of claim 1 further comprising a semiconductor quantum dot.
16. The chemical sensor of claim 15 wherein the semiconductor quantum dot further comprises a linker molecule, the linker molecule selected from the group consisting of a thiol group, a sulphide group, a phosphate group, a sulphate group, a cyano group, a piperidine group, an Fmoc group, and a Boc group.
17. The chemical sensor of claim 15 wherein the semiconductor quantum dot further comprises a detecting molecule, wherein the detecting molecule is bound to the semiconductor quantum dot.
18. The chemical sensor of claim 15 wherein the detecting molecule is selected from the group consisting of proteins, peptides, antibodies, antigens, nucleic acids, peptide nucleic acids, sugars, lipids, glycophosphoinositols, and lipopolysaccharides.
19. The chemical sensor of claim 15 wherein the detecting molecule is an antibody.
20. The chemical sensor of claim 15 wherein the detecting molecule is an antigen.
21. The chemical sensor of claim 20 wherein the detecting molecule is an antigen that binds to an ovarian cancer marker antibody with an affinity (Ka) of at least 106 l/mole.
22. The chemical sensor of claim 21 wherein the Ka is at least 108 l/mole.
23. A method for detecting an analyte in a sample using a chemical sensor, the method comprising the steps of:
i) providing a sample;
ii) providing a semiconductor quantum dot comprising a linker molecule (LM-SQD)
iii) conjugating the analyte in the sample with the LM-SQD thereby producing an analyte-LM-SQD conjugate;
iv) providing the chemical sensor of claim 11 ;
v) incubating the analyte-LM-SQD conjugate with the chemical sensor for a predetermined time period; and
vi) measuring the extent of binding between the analyte-LM-SQD conjugate and the chemical sensor; thereby detecting the analyte in the sample.
24. The method of claim 23 wherein the analyte is an ovarian cancer marker antibody.
25. The method of claim 23 wherein the detecting molecule in the chemical sensor is an antigen that binds to an ovarian cancer marker antibody with an affinity (Ka) of at least 106 l/mole.
26. The method of claim 25 wherein the Ka is at least 108 l/mole.
27. An optical communications device comprising a fiber and the chemical sensor of claim 1 .
28. The optical communications device of claim 27 wherein the fiber is selected from the group consisting of ceramics, glasses, and polymers.
29. The optical communications device of claim 27 wherein the fiber cross-section is D-shaped.
30. The optical communications device of claim 27 wherein the chemical sensor is disposed upon a surface of the fiber.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/396,098 US20080166706A1 (en) | 2005-03-30 | 2006-03-30 | Novel gold nanoparticle aggregates and their applications |
US13/199,563 US9297801B2 (en) | 2005-03-30 | 2011-09-03 | Gold nanoparticle aggregates and their applications |
US15/018,761 US20160153977A1 (en) | 2005-03-30 | 2016-02-08 | Novel gold nanoparticle aggregates and their applications |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66715105P | 2005-03-30 | 2005-03-30 | |
US71180805P | 2005-08-26 | 2005-08-26 | |
US11/396,098 US20080166706A1 (en) | 2005-03-30 | 2006-03-30 | Novel gold nanoparticle aggregates and their applications |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/199,563 Continuation US9297801B2 (en) | 2005-03-30 | 2011-09-03 | Gold nanoparticle aggregates and their applications |
US13/199,563 Division US9297801B2 (en) | 2005-03-30 | 2011-09-03 | Gold nanoparticle aggregates and their applications |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080166706A1 true US20080166706A1 (en) | 2008-07-10 |
Family
ID=39594616
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/396,098 Abandoned US20080166706A1 (en) | 2005-03-30 | 2006-03-30 | Novel gold nanoparticle aggregates and their applications |
US13/199,563 Active 2028-08-16 US9297801B2 (en) | 2005-03-30 | 2011-09-03 | Gold nanoparticle aggregates and their applications |
US15/018,761 Abandoned US20160153977A1 (en) | 2005-03-30 | 2016-02-08 | Novel gold nanoparticle aggregates and their applications |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/199,563 Active 2028-08-16 US9297801B2 (en) | 2005-03-30 | 2011-09-03 | Gold nanoparticle aggregates and their applications |
US15/018,761 Abandoned US20160153977A1 (en) | 2005-03-30 | 2016-02-08 | Novel gold nanoparticle aggregates and their applications |
Country Status (1)
Country | Link |
---|---|
US (3) | US20080166706A1 (en) |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080176212A1 (en) * | 2006-06-14 | 2008-07-24 | William Marsh Rice University | All optical nanoscale sensor |
WO2009137613A2 (en) | 2008-05-06 | 2009-11-12 | Joslin Diabetes Center, Inc. | Methods and compositions for inducing brown adipogenesis |
US20100022020A1 (en) * | 2006-09-01 | 2010-01-28 | Halas Nancy J | Compositions for surface enhanced infrared absorption spectra and methods of using same |
US20100028680A1 (en) * | 2006-06-21 | 2010-02-04 | William Marsh Rice University | Nonconcentric nanoshells and methods of making and using same |
WO2010110931A2 (en) | 2009-03-23 | 2010-09-30 | The Brigham And Women's Hospital, Inc. | Glycoconjugate vaccines |
US20100311605A1 (en) * | 2009-06-03 | 2010-12-09 | National Chiao Tung University | Sensing platform |
US20110044902A1 (en) * | 2007-11-20 | 2011-02-24 | Howard Weiner | Modulation of the Immune Response |
US20110064665A1 (en) * | 2009-09-17 | 2011-03-17 | University Of Louisville Research Foundation, Inc. | Diagnostic and therapeutic nanoparticles |
US20110088311A1 (en) * | 2009-09-18 | 2011-04-21 | Swift Enterprises, Ltd. | Mesitylene As An Octane Enhancer For Automotive Gasoline, Additive For Jet Fuel, And Method Of Enhancing Motor Fuel Octane And Lowering Jet Fuel Carbon Emissions |
US20120212732A1 (en) * | 2011-02-17 | 2012-08-23 | Santori Charles M | Apparatus for performing sers |
EP2615059A1 (en) * | 2010-09-06 | 2013-07-17 | Mytech Co., Ltd. | Method for producing metal complex quantum crystals |
US8520202B2 (en) | 2011-09-15 | 2013-08-27 | Hewlett-Packard Development Company, L.P. | Asymmetrical-nanofinger device for surface-enhanced luminescense |
US20130305881A1 (en) * | 2012-05-16 | 2013-11-21 | Andre M. Gobin | Method for synthesizing self-assembling nanoparticles |
US8605281B2 (en) | 2011-10-13 | 2013-12-10 | Hewlett-Packard Development Company, L.P. | Probe having nano-fingers |
CN104155280A (en) * | 2014-01-26 | 2014-11-19 | 中国科学院长春光学精密机械与物理研究所 | Self-reference quantization detection method of Raman optical fiber sensor |
US9001324B2 (en) | 2010-07-30 | 2015-04-07 | Hewlett-Packard Development Company, L.P. | Optical fiber surface enhanced raman spectroscopy (SERS) probe |
US9244015B2 (en) | 2010-04-20 | 2016-01-26 | Hewlett-Packard Development Company, L.P. | Self-arranging, luminescence-enhancement device for surface-enhanced luminescence |
CN105268966A (en) * | 2015-10-08 | 2016-01-27 | 北京理工大学 | Au@Cu2-deltaX nanoscale crystal and preparation method and application thereof |
US9377409B2 (en) | 2011-07-29 | 2016-06-28 | Hewlett-Packard Development Company, L.P. | Fabricating an apparatus for use in a sensing application |
WO2016154362A1 (en) | 2015-03-23 | 2016-09-29 | The Brigham And Women's Hospital, Inc. | Tolerogenic nanoparticles for treating diabetes mellitus |
CN106290305A (en) * | 2016-10-26 | 2017-01-04 | 中国计量大学 | Raman scattering substrate is strengthened based on optical fiber evanescent field auxiliary surface |
US9636423B2 (en) | 2010-06-02 | 2017-05-02 | The General Hospital Corporation | Optical sensor conjugates for detecting reactive oxygen and/or reactive nitrogen species in vivo |
CN107101992A (en) * | 2017-06-01 | 2017-08-29 | 中国农业大学 | A kind of preparation method of D-type optical fiber surface-enhanced Raman probe |
US20180143133A1 (en) * | 2015-05-18 | 2018-05-24 | INL-International lberian Nanotechnology Laboratory | An optical fibre for use in a system for detection of one or more compounds in a fluid |
US10022791B2 (en) | 2012-05-16 | 2018-07-17 | University Of Louisville Research Foundation, Inc. | Method for synthesizing self-assembling nanoparticles |
WO2020025408A1 (en) | 2018-08-03 | 2020-02-06 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Biocompatible tolerogenic nanoparticles |
US10670582B2 (en) | 2009-06-22 | 2020-06-02 | Massachusetts Eye And Ear Infirmary | Islet1 (ISl1) and hearing loss |
WO2020109352A1 (en) | 2018-11-27 | 2020-06-04 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Nanoparticles for preparing regulatory b cells |
WO2020167912A1 (en) | 2019-02-13 | 2020-08-20 | The Brigham And Women's Hospital, Inc. | Anti-peripheral lymph node addressin antibodies and uses thereof |
CN112940073A (en) * | 2021-01-27 | 2021-06-11 | 中科院过程工程研究所南京绿色制造产业创新研究院 | Functionalized short peptide assembly and preparation method and application thereof |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080166706A1 (en) * | 2005-03-30 | 2008-07-10 | Jin Zhang | Novel gold nanoparticle aggregates and their applications |
KR101530128B1 (en) * | 2013-10-25 | 2015-06-19 | 한국과학기술원 | Synthesis method for AuNPCs with tuned size and shape |
US9913603B2 (en) | 2014-02-12 | 2018-03-13 | California Institute Of Technology | Reflowed gold nanostructures for surface enhanced raman spectroscopy |
WO2015123457A1 (en) | 2014-02-12 | 2015-08-20 | California Institute Of Technology | Plasmonics nanostructures for multiplexing implantable sensors |
WO2016036409A1 (en) | 2014-09-05 | 2016-03-10 | California Institute Of Technology | Surface enhanced raman spectroscopy detection of gases, particles and liquids through nanopillar structures |
US9987609B2 (en) | 2014-09-05 | 2018-06-05 | California Institute Of Technology | Multiplexed surface enhanced Raman sensors for early disease detection and in-situ bacterial monitoring |
WO2016094089A1 (en) | 2014-12-09 | 2016-06-16 | California Institute Of Technonolgy | Fabrication and self-aligned local functionalization of nanocups and various plasmonic nanostructures on flexible substrates for implantable and sensing applications |
TWI756764B (en) * | 2020-07-31 | 2022-03-01 | 國立中興大學 | Photocurrent electrode and photoelectric immunosensing device |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5367060A (en) * | 1991-05-24 | 1994-11-22 | Genentech, Inc. | Structure, production and use of heregulin |
US5579429A (en) * | 1995-09-06 | 1996-11-26 | Dn Labs, Inc. | Laser dye doped fluorescent optical fiber and method of preparation of the same |
US6274323B1 (en) * | 1999-05-07 | 2001-08-14 | Quantum Dot Corporation | Method of detecting an analyte in a sample using semiconductor nanocrystals as a detectable label |
US6361944B1 (en) * | 1996-07-29 | 2002-03-26 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US6579721B1 (en) * | 1999-07-30 | 2003-06-17 | Surromed, Inc. | Biosensing using surface plasmon resonance |
US7361410B2 (en) * | 2003-12-29 | 2008-04-22 | Intel Corporation | External modification of composite organic inorganic nanoclusters comprising raman active organic compound |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6322901B1 (en) * | 1997-11-13 | 2001-11-27 | Massachusetts Institute Of Technology | Highly luminescent color-selective nano-crystalline materials |
US6207392B1 (en) * | 1997-11-25 | 2001-03-27 | The Regents Of The University Of California | Semiconductor nanocrystal probes for biological applications and process for making and using such probes |
US6699723B1 (en) * | 1997-11-25 | 2004-03-02 | The Regents Of The University Of California | Organo luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes |
US6326144B1 (en) * | 1998-09-18 | 2001-12-04 | Massachusetts Institute Of Technology | Biological applications of quantum dots |
ATE512115T1 (en) * | 2003-01-22 | 2011-06-15 | Univ Arkansas | MONODISPERSE NANOCRYSTALS WITH CORE/SHELL AND OTHER COMPLEX STRUCTURES AND PRODUCTION PROCESSES THEREOF |
US20080166706A1 (en) * | 2005-03-30 | 2008-07-10 | Jin Zhang | Novel gold nanoparticle aggregates and their applications |
-
2006
- 2006-03-30 US US11/396,098 patent/US20080166706A1/en not_active Abandoned
-
2011
- 2011-09-03 US US13/199,563 patent/US9297801B2/en active Active
-
2016
- 2016-02-08 US US15/018,761 patent/US20160153977A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5367060A (en) * | 1991-05-24 | 1994-11-22 | Genentech, Inc. | Structure, production and use of heregulin |
US5579429A (en) * | 1995-09-06 | 1996-11-26 | Dn Labs, Inc. | Laser dye doped fluorescent optical fiber and method of preparation of the same |
US6361944B1 (en) * | 1996-07-29 | 2002-03-26 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US6274323B1 (en) * | 1999-05-07 | 2001-08-14 | Quantum Dot Corporation | Method of detecting an analyte in a sample using semiconductor nanocrystals as a detectable label |
US6579721B1 (en) * | 1999-07-30 | 2003-06-17 | Surromed, Inc. | Biosensing using surface plasmon resonance |
US7361410B2 (en) * | 2003-12-29 | 2008-04-22 | Intel Corporation | External modification of composite organic inorganic nanoclusters comprising raman active organic compound |
Cited By (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8045152B2 (en) | 2006-06-14 | 2011-10-25 | William Marsh Rice University | All optical nanoscale sensor |
US20080176212A1 (en) * | 2006-06-14 | 2008-07-24 | William Marsh Rice University | All optical nanoscale sensor |
US20100028680A1 (en) * | 2006-06-21 | 2010-02-04 | William Marsh Rice University | Nonconcentric nanoshells and methods of making and using same |
US8178202B2 (en) * | 2006-06-21 | 2012-05-15 | William Marsh Rice University | Nonconcentric nanoshells with offset core in relation to shell and method of using the same |
US20100022020A1 (en) * | 2006-09-01 | 2010-01-28 | Halas Nancy J | Compositions for surface enhanced infrared absorption spectra and methods of using same |
US9895440B2 (en) | 2007-11-20 | 2018-02-20 | The Brigham And Women's Hospital, Inc. | Modulation of the immune response |
US20110044902A1 (en) * | 2007-11-20 | 2011-02-24 | Howard Weiner | Modulation of the Immune Response |
US11253589B2 (en) | 2007-11-20 | 2022-02-22 | The Brigham And Women's Hospital, Inc. | Modulation of the immune response |
US9028798B2 (en) | 2007-11-20 | 2015-05-12 | The Brigham And Women's Hospital, Inc. | Modulation of the immune response |
WO2009137613A2 (en) | 2008-05-06 | 2009-11-12 | Joslin Diabetes Center, Inc. | Methods and compositions for inducing brown adipogenesis |
WO2010110931A2 (en) | 2009-03-23 | 2010-09-30 | The Brigham And Women's Hospital, Inc. | Glycoconjugate vaccines |
US20100311605A1 (en) * | 2009-06-03 | 2010-12-09 | National Chiao Tung University | Sensing platform |
US10670582B2 (en) | 2009-06-22 | 2020-06-02 | Massachusetts Eye And Ear Infirmary | Islet1 (ISl1) and hearing loss |
WO2011034570A1 (en) * | 2009-09-17 | 2011-03-24 | University Of Louisville Research Foundation, Inc. | Diagnostic and therapeutic nanoparticles |
US20110064665A1 (en) * | 2009-09-17 | 2011-03-17 | University Of Louisville Research Foundation, Inc. | Diagnostic and therapeutic nanoparticles |
US20110088311A1 (en) * | 2009-09-18 | 2011-04-21 | Swift Enterprises, Ltd. | Mesitylene As An Octane Enhancer For Automotive Gasoline, Additive For Jet Fuel, And Method Of Enhancing Motor Fuel Octane And Lowering Jet Fuel Carbon Emissions |
US9244015B2 (en) | 2010-04-20 | 2016-01-26 | Hewlett-Packard Development Company, L.P. | Self-arranging, luminescence-enhancement device for surface-enhanced luminescence |
US10357574B2 (en) | 2010-06-02 | 2019-07-23 | The General Hospital Corporation | Optical sensor conjugates for detecting reactive oxygen and/or reactive nitrogen species in vivo |
US9636423B2 (en) | 2010-06-02 | 2017-05-02 | The General Hospital Corporation | Optical sensor conjugates for detecting reactive oxygen and/or reactive nitrogen species in vivo |
US9001324B2 (en) | 2010-07-30 | 2015-04-07 | Hewlett-Packard Development Company, L.P. | Optical fiber surface enhanced raman spectroscopy (SERS) probe |
EP2615059A4 (en) * | 2010-09-06 | 2014-03-12 | Mytech Co Ltd | Method for producing metal complex quantum crystals |
CN104880452A (en) * | 2010-09-06 | 2015-09-02 | 米特奇有限公司 | Method for producing metal complex quantum crystals |
EP2615059A1 (en) * | 2010-09-06 | 2013-07-17 | Mytech Co., Ltd. | Method for producing metal complex quantum crystals |
JP5964234B2 (en) * | 2010-09-06 | 2016-08-03 | 有限会社マイテック | Method for producing metal complex quantum crystal |
KR101832206B1 (en) * | 2010-09-06 | 2018-02-26 | 유겐가이샤 마이테크 | Method for producing metal complex quantum crystals |
JP2016197114A (en) * | 2010-09-06 | 2016-11-24 | 有限会社マイテック | Quantum crystal substrate |
US8593629B2 (en) * | 2011-02-17 | 2013-11-26 | Hewlett-Packard Development Company, L.P. | Apparatus for performing SERS |
US20120212732A1 (en) * | 2011-02-17 | 2012-08-23 | Santori Charles M | Apparatus for performing sers |
US9377409B2 (en) | 2011-07-29 | 2016-06-28 | Hewlett-Packard Development Company, L.P. | Fabricating an apparatus for use in a sensing application |
US8520202B2 (en) | 2011-09-15 | 2013-08-27 | Hewlett-Packard Development Company, L.P. | Asymmetrical-nanofinger device for surface-enhanced luminescense |
US8605281B2 (en) | 2011-10-13 | 2013-12-10 | Hewlett-Packard Development Company, L.P. | Probe having nano-fingers |
US20130305881A1 (en) * | 2012-05-16 | 2013-11-21 | Andre M. Gobin | Method for synthesizing self-assembling nanoparticles |
US10022791B2 (en) | 2012-05-16 | 2018-07-17 | University Of Louisville Research Foundation, Inc. | Method for synthesizing self-assembling nanoparticles |
US9266172B2 (en) * | 2012-05-16 | 2016-02-23 | University Of Louisville Research Foundation, Inc. | Method for synthesizing self-assembling nanoparticles |
CN104155280A (en) * | 2014-01-26 | 2014-11-19 | 中国科学院长春光学精密机械与物理研究所 | Self-reference quantization detection method of Raman optical fiber sensor |
WO2016154362A1 (en) | 2015-03-23 | 2016-09-29 | The Brigham And Women's Hospital, Inc. | Tolerogenic nanoparticles for treating diabetes mellitus |
US10451549B2 (en) * | 2015-05-18 | 2019-10-22 | INL-International Iberian Nanotechnology Laboratory | Optical fibre for use in a system for detection of one or more compounds in a fluid |
US20180143133A1 (en) * | 2015-05-18 | 2018-05-24 | INL-International lberian Nanotechnology Laboratory | An optical fibre for use in a system for detection of one or more compounds in a fluid |
CN105268966A (en) * | 2015-10-08 | 2016-01-27 | 北京理工大学 | Au@Cu2-deltaX nanoscale crystal and preparation method and application thereof |
CN106290305A (en) * | 2016-10-26 | 2017-01-04 | 中国计量大学 | Raman scattering substrate is strengthened based on optical fiber evanescent field auxiliary surface |
CN107101992A (en) * | 2017-06-01 | 2017-08-29 | 中国农业大学 | A kind of preparation method of D-type optical fiber surface-enhanced Raman probe |
WO2020025408A1 (en) | 2018-08-03 | 2020-02-06 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Biocompatible tolerogenic nanoparticles |
WO2020109352A1 (en) | 2018-11-27 | 2020-06-04 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Nanoparticles for preparing regulatory b cells |
WO2020167912A1 (en) | 2019-02-13 | 2020-08-20 | The Brigham And Women's Hospital, Inc. | Anti-peripheral lymph node addressin antibodies and uses thereof |
CN112940073A (en) * | 2021-01-27 | 2021-06-11 | 中科院过程工程研究所南京绿色制造产业创新研究院 | Functionalized short peptide assembly and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
US20120142119A1 (en) | 2012-06-07 |
US9297801B2 (en) | 2016-03-29 |
US20160153977A1 (en) | 2016-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9297801B2 (en) | Gold nanoparticle aggregates and their applications | |
US8717558B2 (en) | Liquid core photonic crystal fiber biosensors using surface enhanced Raman scattering and methods for their use | |
US8137759B2 (en) | Gold nanostructures and methods of use | |
Li et al. | Plasmon-enhanced optical sensors: a review | |
Sanles-Sobrido et al. | Label-free SERS detection of relevant bioanalytes on silver-coated carbon nanotubes: the case of cocaine | |
CA2162996C (en) | Apparatus and methods for multianalyte homogeneous fluoroimmunoassays | |
US10215753B2 (en) | Method for the topographically-selective passivation of micro- and nanoscale devices | |
JP2001504213A (en) | Chemical / biochemical optical sensors | |
US20070020144A1 (en) | Functionalization of air hole arrays of photonic crystal fibers | |
CZ347196A3 (en) | Method of detecting evanescently excited luminescence | |
Dinish et al. | Surface‐enhanced Raman scattering‐active photonic crystal fiber probe: towards next generation liquid biopsy sensor with ultra high sensitivity | |
Credi et al. | Fiber-cap biosensors for SERS analysis of liquid samples | |
US20120002913A1 (en) | Photonic crystal sensor | |
Loyez et al. | Pf HRP2 detection using plasmonic optrodes: performance analysis | |
Aparicio et al. | Silicon oxynitride waveguides as evanescent-field-based fluorescent biosensors | |
Zhang et al. | Multi-targeting single fiber-optic biosensor based on evanescent wave and quantum dots | |
Sepe et al. | Anisotropic fluorescence emission and photobleaching at the surface of one-dimensional photonic crystals sustaining bloch surface waves. ii. experiments | |
Martinez et al. | Pathogen detection using single mode planar optical waveguides | |
US10620120B2 (en) | Nanoplasmonic devices and applications thereof | |
US11378516B2 (en) | Label-free single molecule spectroscopy and detection | |
Noestheden et al. | Synthesis and characterization of CN-modified protein analogues as potential vibrational contrast agents | |
US12078595B2 (en) | Nanoplasmonic devices and applications thereof | |
Maphanga et al. | Detection of mycobacterium tuberculosis using gold nanoparticles conjugated to TB antibodies | |
Mohammed | Harnessing the plasmonic properties of gold nanoparticles: functionalization strategies coupled with novel spectroscopic tools | |
Jana | Biodetection using fluorescence energy transfer from Quantum dot excited whispering gallery modes to fluorescent acceptors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, CALIF Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ZHANG, JIN;SCHWARTZBERG, ADAM;NORMAN, THADDEUS;AND OTHERS;SIGNING DATES FROM 20070124 TO 20070130;REEL/FRAME:041114/0123 Owner name: UNIVERSITY OF SOUTH FLORIDA, FLORIDA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SUTPHEN, REBECCA;REEL/FRAME:041114/0133 Effective date: 20070130 |